SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Relmada Therapeutics, Inc. – ‘10-K’ for 12/31/22 – ‘JSON’

On:  Thursday, 3/23/23, at 4:49pm ET   ·   For:  12/31/22   ·   Accession #:  1213900-23-22463   ·   File #:  1-39082

Previous ‘10-K’:  ‘10-K’ on 3/25/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 3/19/24 for 12/31/23   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/23/23  Relmada Therapeutics, Inc.        10-K       12/31/22   55:4.4M                                   EdgarAgents LLC/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    952K 
 2: EX-23.1     Consent of Marcum LLP                               HTML     15K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     19K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     19K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     16K 
12: R1          Document And Entity Information                     HTML     85K 
13: R2          Consolidated Balance Sheets                         HTML     95K 
14: R3          Consolidated Balance Sheets (Parentheticals)        HTML     36K 
15: R4          Consolidated Statements of Operations               HTML     59K 
16: R5          Consolidated Statements of Operations               HTML     25K 
                (Parentheticals)                                                 
17: R6          Consolidated Statements of Changes in               HTML     77K 
                Stockholders? Equity                                             
18: R7          Condensed Consolidated Statements of Cash Flows     HTML     92K 
19: R8          Business                                            HTML     19K 
20: R9          Summary of Significant Accounting Policies          HTML     45K 
21: R10         Prepaid Expenses                                    HTML     21K 
22: R11         Accrued Expenses                                    HTML     21K 
23: R12         Stockholders' Equity                                HTML     65K 
24: R13         Income Taxes                                        HTML     34K 
25: R14         Commitments and Contingencies                       HTML     30K 
26: R15         Related Party Transactions                          HTML     21K 
27: R16         Other Postretirement Benefit Plan                   HTML     22K 
28: R17         Subsequent Events                                   HTML     19K 
29: R18         Accounting Policies, by Policy (Policies)           HTML     83K 
30: R19         Summary of Significant Accounting Policies          HTML     21K 
                (Tables)                                                         
31: R20         Prepaid Expenses (Tables)                           HTML     21K 
32: R21         Accrued Expenses (Tables)                           HTML     21K 
33: R22         Stockholders' Equity (Tables)                       HTML     45K 
34: R23         Income Taxes (Tables)                               HTML     29K 
35: R24         Summary of Significant Accounting Policies          HTML     46K 
                (Details)                                                        
36: R25         Summary of Significant Accounting Policies          HTML     23K 
                (Details) - Schedule of anti-dilutive securities                 
37: R26         Prepaid Expenses (Details) - Schedule of prepaid    HTML     27K 
                expenses                                                         
38: R27         Accrued Expenses (Details) - Schedule of accrued    HTML     29K 
                expenses                                                         
39: R28         Stockholders' Equity (Details)                      HTML    349K 
40: R29         Stockholders' Equity (Details) - Schedule of        HTML     65K 
                changes in options                                               
41: R30         Stockholders' Equity (Details) - Schedule of        HTML     35K 
                unrecognized stock-based compensation expense                    
42: R31         Stockholders' Equity (Details) - Schedule of the    HTML     33K 
                changes in outstanding warrants                                  
43: R32         Stockholders' Equity (Details) - Schedule of        HTML     23K 
                stock-based compensation expense                                 
44: R33         Income Taxes (Details)                              HTML     25K 
45: R34         Income Taxes (Details) - Schedule of deferred tax   HTML     39K 
                assets                                                           
46: R35         Income Taxes (Details) - Schedule of reconcilation  HTML     34K 
                of the statutory tax rate to the effective tax                   
                rate                                                             
47: R36         Commitments and Contingencies (Details)             HTML     60K 
48: R37         Related Party Transactions (Details)                HTML     30K 
49: R38         Other Postretirement Benefit Plan (Details)         HTML     20K 
50: R39         Subsequent Events (Details)                         HTML     33K 
53: XML         IDEA XML File -- Filing Summary                      XML     93K 
51: XML         XBRL Instance -- f10k2022_relmadatherap_htm          XML    686K 
52: EXCEL       IDEA Workbook of Financial Reports                  XLSX    116K 
 8: EX-101.CAL  XBRL Calculations -- rlmd-20221231_cal               XML     73K 
 9: EX-101.DEF  XBRL Definitions -- rlmd-20221231_def                XML    532K 
10: EX-101.LAB  XBRL Labels -- rlmd-20221231_lab                     XML   1.11M 
11: EX-101.PRE  XBRL Presentations -- rlmd-20221231_pre              XML    534K 
 7: EX-101.SCH  XBRL Schema -- rlmd-20221231                         XSD    142K 
54: JSON        XBRL Instance as JSON Data -- MetaLinks              284±   423K 
55: ZIP         XBRL Zipped Folder -- 0001213900-23-022463-xbrl      Zip    280K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"instance":  {
    "f10k2022_relmadatherap.htm":  {
        "axisCustom":  0,
        "axisStandard":  15,
        "baseTaxonomies":  {
            "http://fasb.org/us-gaap/2022":  498,
            "http://xbrl.sec.gov/dei/2022":  37
            },
        "contextCount":  143,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "rlmd-20221231_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "rlmd-20221231_def.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "f10k2022_relmadatherap.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "rlmd-20221231_lab.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "rlmd-20221231_pre.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "rlmd-20221231.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
                    "https://xbrl.sec.gov/country/2022/country-2022.xsd",
                    "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
                    "https://xbrl.sec.gov/sic/2022/sic-2022.xsd"
                    ]
                }
            },
        "elementCount":  408,
        "entityCount":  1,
        "hidden":  {
            "http://fasb.org/us-gaap/2022":  43,
            "http://relmada.com/20221231":  20,
            "http://xbrl.sec.gov/dei/2022":  3,
            "total":  66
            },
        "keyCustom":  67,
        "keyStandard":  228,
        "memberCustom":  14,
        "memberStandard":  12,
        "nsprefix":  "rlmd",
        "nsuri":  "http://relmada.com/20221231",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:EntityRegistrantName",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "000 - Document - Document And Entity Information",
                "menuCat":  "Cover",
                "order":  "1",
                "role":  "http://relmada.com/role/DocumentAndEntityInformation",
                "shortName":  "Document And Entity Information",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:EntityRegistrantName",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "rlmd:PrepaidExpensesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "009 - Disclosure - Prepaid Expenses",
                "menuCat":  "Notes",
                "order":  "10",
                "role":  "http://relmada.com/role/PrepaidExpenses",
                "shortName":  "Prepaid Expenses",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "rlmd:PrepaidExpensesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "010 - Disclosure - Accrued Expenses",
                "menuCat":  "Notes",
                "order":  "11",
                "role":  "http://relmada.com/role/AccruedExpenses",
                "shortName":  "Accrued Expenses",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "011 - Disclosure - Stockholders' Equity",
                "menuCat":  "Notes",
                "order":  "12",
                "role":  "http://relmada.com/role/StockholdersEquity",
                "shortName":  "Stockholders' Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "012 - Disclosure - Income Taxes",
                "menuCat":  "Notes",
                "order":  "13",
                "role":  "http://relmada.com/role/IncomeTaxes",
                "shortName":  "Income Taxes",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "013 - Disclosure - Commitments and Contingencies",
                "menuCat":  "Notes",
                "order":  "14",
                "role":  "http://relmada.com/role/CommitmentsandContingencies",
                "shortName":  "Commitments and Contingencies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "014 - Disclosure - Related Party Transactions",
                "menuCat":  "Notes",
                "order":  "15",
                "role":  "http://relmada.com/role/RelatedPartyTransactions",
                "shortName":  "Related Party Transactions",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "015 - Disclosure - Other Postretirement Benefit Plan",
                "menuCat":  "Notes",
                "order":  "16",
                "role":  "http://relmada.com/role/OtherPostretirementBenefitPlan",
                "shortName":  "Other Postretirement Benefit Plan",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "016 - Disclosure - Subsequent Events",
                "menuCat":  "Notes",
                "order":  "17",
                "role":  "http://relmada.com/role/SubsequentEvents",
                "shortName":  "Subsequent Events",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "017 - Disclosure - Accounting Policies, by Policy (Policies)",
                "menuCat":  "Policies",
                "order":  "18",
                "role":  "http://relmada.com/role/AccountingPoliciesByPolicy",
                "shortName":  "Accounting Policies, by Policy (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "018 - Disclosure - Summary of Significant Accounting Policies (Tables)",
                "menuCat":  "Tables",
                "order":  "19",
                "role":  "http://relmada.com/role/SummaryofSignificantAccountingPoliciesTables",
                "shortName":  "Summary of Significant Accounting Policies (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "001 - Statement - Consolidated Balance Sheets",
                "menuCat":  "Statements",
                "order":  "2",
                "role":  "http://relmada.com/role/ConsolidatedBalanceSheet",
                "shortName":  "Consolidated Balance Sheets",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashAndCashEquivalentsAtCarryingValue",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "019 - Disclosure - Prepaid Expenses (Tables)",
                "menuCat":  "Tables",
                "order":  "20",
                "role":  "http://relmada.com/role/PrepaidExpensesTables",
                "shortName":  "Prepaid Expenses (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "020 - Disclosure - Accrued Expenses (Tables)",
                "menuCat":  "Tables",
                "order":  "21",
                "role":  "http://relmada.com/role/AccruedExpensesTables",
                "shortName":  "Accrued Expenses (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "021 - Disclosure - Stockholders' Equity (Tables)",
                "menuCat":  "Tables",
                "order":  "22",
                "role":  "http://relmada.com/role/StockholdersEquityTables",
                "shortName":  "Stockholders' Equity (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "022 - Disclosure - Income Taxes (Tables)",
                "menuCat":  "Tables",
                "order":  "23",
                "role":  "http://relmada.com/role/IncomeTaxesTables",
                "shortName":  "Income Taxes (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetCashProvidedByUsedInOperatingActivities",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "023 - Disclosure - Summary of Significant Accounting Policies (Details)",
                "menuCat":  "Details",
                "order":  "24",
                "role":  "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails",
                "shortName":  "Summary of Significant Accounting Policies (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:RetainedEarningsAppropriated",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "024 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive securities",
                "menuCat":  "Details",
                "order":  "25",
                "role":  "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable",
                "shortName":  "Summary of Significant Accounting Policies (Details) - Schedule of anti-dilutive securities",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "ix:continuation",
                        "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PrepaidInsurance",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "025 - Disclosure - Prepaid Expenses (Details) - Schedule of prepaid expenses",
                "menuCat":  "Details",
                "order":  "26",
                "role":  "http://relmada.com/role/ScheduleofprepaidexpensesTable",
                "shortName":  "Prepaid Expenses (Details) - Schedule of prepaid expenses",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PrepaidInsurance",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "rlmd:AccruedResearchAndDevelopmentExpenseCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "026 - Disclosure - Accrued Expenses (Details) - Schedule of accrued expenses",
                "menuCat":  "Details",
                "order":  "27",
                "role":  "http://relmada.com/role/ScheduleofaccruedexpensesTable",
                "shortName":  "Accrued Expenses (Details) - Schedule of accrued expenses",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "rlmd:AccruedResearchAndDevelopmentExpenseCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "027 - Disclosure - Stockholders' Equity (Details)",
                "menuCat":  "Details",
                "order":  "28",
                "role":  "http://relmada.com/role/StockholdersEquityDetails",
                "shortName":  "Stockholders' Equity (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c4",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "028 - Disclosure - Stockholders' Equity (Details) - Schedule of changes in options",
                "menuCat":  "Details",
                "order":  "29",
                "role":  "http://relmada.com/role/ScheduleofchangesinoptionsTable",
                "shortName":  "Stockholders' Equity (Details) - Schedule of changes in options",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c11",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usdPershares",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "002 - Statement - Consolidated Balance Sheets (Parentheticals)",
                "menuCat":  "Statements",
                "order":  "3",
                "role":  "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals",
                "shortName":  "Consolidated Balance Sheets (Parentheticals)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "3",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usdPershares",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c93",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                    "reportCount":  1,
                    "unitRef":  "pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "029 - Disclosure - Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense",
                "menuCat":  "Details",
                "order":  "30",
                "role":  "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable",
                "shortName":  "Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "2",
                    "lang":  null,
                    "name":  "rlmd:DividendYield",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "pure",
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "rlmd:ScheduleOfShareBasedCompensationWarrantsActivityTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c4",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "030 - Disclosure - Stockholders' Equity (Details) - Schedule of the changes in outstanding warrants",
                "menuCat":  "Details",
                "order":  "31",
                "role":  "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable",
                "shortName":  "Stockholders' Equity (Details) - Schedule of the changes in outstanding warrants",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "rlmd:ScheduleOfShareBasedCompensationWarrantsActivityTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c11",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AllocatedShareBasedCompensationExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "031 - Disclosure - Stockholders' Equity (Details) - Schedule of stock-based compensation expense",
                "menuCat":  "Details",
                "order":  "32",
                "role":  "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable",
                "shortName":  "Stockholders' Equity (Details) - Schedule of stock-based compensation expense",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:AllocatedShareBasedCompensationExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c126",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "rlmd:DescriptionOfClassLifeChanges",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "032 - Disclosure - Income Taxes (Details)",
                "menuCat":  "Details",
                "order":  "33",
                "role":  "http://relmada.com/role/IncomeTaxesDetails",
                "shortName":  "Income Taxes (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c126",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "rlmd:DescriptionOfClassLifeChanges",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "033 - Disclosure - Income Taxes (Details) - Schedule of deferred tax assets",
                "menuCat":  "Details",
                "order":  "34",
                "role":  "http://relmada.com/role/ScheduleofdeferredtaxassetsTable",
                "shortName":  "Income Taxes (Details) - Schedule of deferred tax assets",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "034 - Disclosure - Income Taxes (Details) - Schedule of reconcilation of the statutory tax rate to the effective tax rate",
                "menuCat":  "Details",
                "order":  "35",
                "role":  "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable",
                "shortName":  "Income Taxes (Details) - Schedule of reconcilation of the statutory tax rate to the effective tax rate",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "4",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "pure",
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "rlmd:PaymentForLicense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "035 - Disclosure - Commitments and Contingencies (Details)",
                "menuCat":  "Details",
                "order":  "36",
                "role":  "http://relmada.com/role/CommitmentsandContingenciesDetails",
                "shortName":  "Commitments and Contingencies (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c3",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "rlmd:PaymentForLicense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c135",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SeveranceCosts1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "036 - Disclosure - Related Party Transactions (Details)",
                "menuCat":  "Details",
                "order":  "37",
                "role":  "http://relmada.com/role/RelatedPartyTransactionsDetails",
                "shortName":  "Related Party Transactions (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c135",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SeveranceCosts1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "037 - Disclosure - Other Postretirement Benefit Plan (Details)",
                "menuCat":  "Details",
                "order":  "38",
                "role":  "http://relmada.com/role/OtherPostretirementBenefitPlanDetails",
                "shortName":  "Other Postretirement Benefit Plan (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c140",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "038 - Disclosure - Subsequent Events (Details)",
                "menuCat":  "Details",
                "order":  "39",
                "role":  "http://relmada.com/role/SubsequentEventsDetails",
                "shortName":  "Subsequent Events (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "p",
                        "ix:continuation",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c140",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "shares",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "003 - Statement - Consolidated Statements of Operations",
                "menuCat":  "Statements",
                "order":  "4",
                "role":  "http://relmada.com/role/ConsolidatedIncomeStatement",
                "shortName":  "Consolidated Statements of Operations",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ResearchAndDevelopmentExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R5":  {
                "firstAnchor":  null,
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "004 - Statement - Consolidated Statements of Operations (Parentheticals)",
                "menuCat":  "Statements",
                "order":  "5",
                "role":  "http://relmada.com/role/ConsolidatedIncomeStatement_Parentheticals",
                "shortName":  "Consolidated Statements of Operations (Parentheticals)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  null
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c8",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "005 - Statement - Consolidated Statements of Changes in Stockholders\u2019 Equity",
                "menuCat":  "Statements",
                "order":  "6",
                "role":  "http://relmada.com/role/ShareholdersEquityType2or3",
                "shortName":  "Consolidated Statements of Changes in Stockholders\u2019 Equity",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c8",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "006 - Statement - Condensed Consolidated Statements of Cash Flows",
                "menuCat":  "Statements",
                "order":  "7",
                "role":  "http://relmada.com/role/ConsolidatedCashFlow",
                "shortName":  "Condensed Consolidated Statements of Cash Flows",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c7",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "usd",
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "007 - Disclosure - Business",
                "menuCat":  "Notes",
                "order":  "8",
                "role":  "http://relmada.com/role/Business",
                "shortName":  "Business",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "008 - Disclosure - Summary of Significant Accounting Policies",
                "menuCat":  "Notes",
                "order":  "9",
                "role":  "http://relmada.com/role/SummaryofSignificantAccountingPolicies",
                "shortName":  "Summary of Significant Accounting Policies",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "div",
                        "body",
                        "html"
                        ],
                    "baseRef":  "f10k2022_relmadatherap.htm",
                    "contextRef":  "c0",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  31,
        "tag":  {
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag",
                            "terseLabel":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AuditorFirmId":  {
                "auth_ref":  [
                    "r379",
                    "r380",
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "PCAOB issued Audit Firm Identifier",
                            "label":  "Auditor Firm ID",
                            "terseLabel":  "Auditor Firm ID"
                            }
                        }
                    },
                "localname":  "AuditorFirmId",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "nonemptySequenceNumberItemType"
                },
            "dei_AuditorLocation":  {
                "auth_ref":  [
                    "r379",
                    "r380",
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Auditor Location",
                            "terseLabel":  "Auditor Location"
                            }
                        }
                    },
                "localname":  "AuditorLocation",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "internationalNameItemType"
                },
            "dei_AuditorName":  {
                "auth_ref":  [
                    "r379",
                    "r380",
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Auditor Name",
                            "terseLabel":  "Auditor Name"
                            }
                        }
                    },
                "localname":  "AuditorName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "internationalNameItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code",
                            "terseLabel":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date",
                            "terseLabel":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentAnnualReport":  {
                "auth_ref":  [
                    "r379",
                    "r380",
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an annual report.",
                            "label":  "Document Annual Report",
                            "terseLabel":  "Document Annual Report"
                            }
                        }
                    },
                "localname":  "DocumentAnnualReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus",
                            "terseLabel":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus",
                            "terseLabel":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentInformationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
                            }
                        }
                    },
                "localname":  "DocumentInformationLineItems",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_DocumentInformationTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
                            }
                        }
                    },
                "localname":  "DocumentInformationTable",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date",
                            "terseLabel":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r382"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report",
                            "terseLabel":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type",
                            "terseLabel":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One",
                            "terseLabel":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine2":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 2 such as Street or Suite number",
                            "label":  "Entity Address, Address Line Two",
                            "terseLabel":  "Entity Address, Address Line Two"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine2",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town",
                            "terseLabel":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code",
                            "terseLabel":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province",
                            "terseLabel":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r377"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key",
                            "terseLabel":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding",
                            "terseLabel":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status",
                            "terseLabel":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r377"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company",
                            "terseLabel":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number",
                            "terseLabel":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r377"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category",
                            "terseLabel":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code",
                            "terseLabel":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r383"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current",
                            "terseLabel":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityPublicFloat":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
                            "label":  "Entity Public Float",
                            "terseLabel":  "Entity Public Float"
                            }
                        }
                    },
                "localname":  "EntityPublicFloat",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r377"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name",
                            "terseLabel":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r377"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company",
                            "terseLabel":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r377"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business",
                            "terseLabel":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r377"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number",
                            "terseLabel":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_EntityVoluntaryFilers":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
                            "label":  "Entity Voluntary Filers",
                            "terseLabel":  "Entity Voluntary Filers"
                            }
                        }
                    },
                "localname":  "EntityVoluntaryFilers",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "auth_ref":  [
                    "r384"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
                            "label":  "Entity Well-known Seasoned Issuer",
                            "terseLabel":  "Entity Well-known Seasoned Issuer"
                            }
                        }
                    },
                "localname":  "EntityWellKnownSeasonedIssuer",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_IcfrAuditorAttestationFlag":  {
                "auth_ref":  [
                    "r379",
                    "r380",
                    "r381"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ICFR Auditor Attestation Flag",
                            "terseLabel":  "ICFR Auditor Attestation Flag"
                            }
                        }
                    },
                "localname":  "IcfrAuditorAttestationFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number",
                            "terseLabel":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r376"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security",
                            "terseLabel":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r378"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name",
                            "terseLabel":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol",
                            "terseLabel":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://relmada.com/role/DocumentAndEntityInformation"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "rlmd_AccruedResearchAndDevelopmentExpenseCurrent":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for research and development.",
                            "label":  "Accrued Research And Development Expense Current",
                            "terseLabel":  "Research and development"
                            }
                        }
                    },
                "localname":  "AccruedResearchAndDevelopmentExpenseCurrent",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_AdditionalSharesOfCommonStock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additional shares of common stock.",
                            "label":  "Additional Shares Of Common Stock",
                            "terseLabel":  "Additional shares of common stock (in Shares)"
                            }
                        }
                    },
                "localname":  "AdditionalSharesOfCommonStock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_AggregateIntrinsicValueOutstandingAndExpectedToVestExercised1":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate Intrinsic Value, Outstanding and expected to vest, Exercised.",
                            "label":  "Aggregate Intrinsic Value Outstanding And Expected To Vest Exercised1",
                            "terseLabel":  "Aggregate Intrinsic Value, Outstanding and expected to vest, Exercised"
                            }
                        }
                    },
                "localname":  "AggregateIntrinsicValueOutstandingAndExpectedToVestExercised1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_AggregateIntrinsicValueOutstandingAndExpectedToVestForfeited1":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate Intrinsic Value, Outstanding and expected to vest, Forfeited.",
                            "label":  "Aggregate Intrinsic Value Outstanding And Expected To Vest Forfeited1",
                            "terseLabel":  "Aggregate Intrinsic Value, Outstanding and expected to vest, Forfeited"
                            }
                        }
                    },
                "localname":  "AggregateIntrinsicValueOutstandingAndExpectedToVestForfeited1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_AggregateIntrinsicValueOutstandingAndExpectedToVestGranted1":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate intrinsic value.",
                            "label":  "Aggregate Intrinsic Value Outstanding And Expected To Vest Granted1",
                            "terseLabel":  "Aggregate Intrinsic Value, Outstanding and expected to vest, Granted"
                            }
                        }
                    },
                "localname":  "AggregateIntrinsicValueOutstandingAndExpectedToVestGranted1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_ArbormentisLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Arbormentis LLCMember",
                            "terseLabel":  "Arbormentis LLC [Member]"
                            }
                        }
                    },
                "localname":  "ArbormentisLLCMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_AttorneysFees":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Attorneys fees.",
                            "label":  "Attorneys Fees",
                            "terseLabel":  "Attorneys fees"
                            }
                        }
                    },
                "localname":  "AttorneysFees",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_BlackScholesOptionPricingModelMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Black Scholes Option Pricing Model Member",
                            "terseLabel":  "Black Scholes Option Pricing Model [Member]"
                            }
                        }
                    },
                "localname":  "BlackScholesOptionPricingModelMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_BusinessCombinationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Business Combination Member",
                            "terseLabel":  "Business Combination [Member]"
                            }
                        }
                    },
                "localname":  "BusinessCombinationMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_COVID19PolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to covid-19 that may impact the entity's financial reporting.",
                            "label":  "COVID19 Policy Text Block",
                            "terseLabel":  "COVID-19"
                            }
                        }
                    },
                "localname":  "COVID19PolicyTextBlock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "rlmd_CashlessEexerciseOfWarrants":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cashless exercise of warrants for common stock.",
                            "label":  "Cashless Eexercise Of Warrants",
                            "terseLabel":  "Proceeds from warrants exercised for common stock"
                            }
                        }
                    },
                "localname":  "CashlessEexerciseOfWarrants",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_CashlessExerciseOfOptionsForCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cashless exercise of options for common stock.",
                            "label":  "Cashless Exercise Of Options For Common Stock",
                            "terseLabel":  "Net exercise of Pre-funded warrants"
                            }
                        }
                    },
                "localname":  "CashlessExerciseOfOptionsForCommonStock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_CashlessExerciseOfWarrant":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cashless exercise of warrants.",
                            "label":  "Cashless Exercise Of Warrant",
                            "terseLabel":  "Cashless exercise of warrants (in Shares)"
                            }
                        }
                    },
                "localname":  "CashlessExerciseOfWarrant",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_CashlessExerciseOfWarrants":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cashless exercise of warrants.",
                            "label":  "Cashless Exercise Of Warrants",
                            "terseLabel":  "Cashless exercise of warrants"
                            }
                        }
                    },
                "localname":  "CashlessExerciseOfWarrants",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_CashlessExerciseOfWarrantsForCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cashless exercise of warrants for common stock.",
                            "label":  "Cashless Exercise Of Warrants For Common Stock",
                            "terseLabel":  "Share exchange for Pre-funded warrants"
                            }
                        }
                    },
                "localname":  "CashlessExerciseOfWarrantsForCommonStock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_CashlessExerciseOfWarrantsValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of cashless exercise of warrants.",
                            "label":  "Cashless Exercise Of Warrants Value",
                            "terseLabel":  "Exercise of warrants (in Dollars)"
                            }
                        }
                    },
                "localname":  "CashlessExerciseOfWarrantsValue",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_ClassOfWarrantsOrRightExercisePriceOfWarrantsOrRights1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise price per share or per unit of warrants or rights outstanding.",
                            "label":  "Class Of Warrants Or Right Exercise Price Of Warrants Or Rights1",
                            "terseLabel":  "Exercise price per share (in Dollars per share)"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantsOrRightExercisePriceOfWarrantsOrRights1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "rlmd_CommitmentsandContingenciesDetailsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies (Details) [Line Items]"
                            }
                        }
                    },
                "localname":  "CommitmentsandContingenciesDetailsLineItems",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_CommitmentsandContingenciesDetailsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies (Details) [Table]"
                            }
                        }
                    },
                "localname":  "CommitmentsandContingenciesDetailsTable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_CommonStockWarrantsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common Stock Warrants Member",
                            "terseLabel":  "Common stock warrants [Member]"
                            }
                        }
                    },
                "localname":  "CommonStockWarrantsMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_ConsultantsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultants Member",
                            "terseLabel":  "Consultants [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantsMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_ConsultantsOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultants One Member",
                            "terseLabel":  "Consultants One [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantsOneMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_DeferredTaxAssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets Abstract",
                            "terseLabel":  "Deferred tax assets:"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_DescriptionOfClassLifeChanges":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of class life changes.",
                            "label":  "Description Of Class Life Changes",
                            "terseLabel":  "Description of class life changes"
                            }
                        }
                    },
                "localname":  "DescriptionOfClassLifeChanges",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_DescriptionOfRightsGrantedToLicenseAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of rights granted to license agreement.",
                            "label":  "Description Of Rights Granted To License Agreement",
                            "terseLabel":  "Description of rights granted to license agreement"
                            }
                        }
                    },
                "localname":  "DescriptionOfRightsGrantedToLicenseAgreement",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_DividendYield":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Dividend yield.",
                            "label":  "Dividend Yield",
                            "terseLabel":  "Dividend yield"
                            }
                        }
                    },
                "localname":  "DividendYield",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "rlmd_DocumentAndEntityInformationAbstract":  {
                "auth_ref":  [
                    ],
                "localname":  "DocumentAndEntityInformationAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_DrVitoloMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Dr Vitolo Member",
                            "terseLabel":  "Dr.  Vitolo [Member]"
                            }
                        }
                    },
                "localname":  "DrVitoloMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_DrWesselMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Dr Wessel Member",
                            "terseLabel":  "Dr.  Wessel [Member]"
                            }
                        }
                    },
                "localname":  "DrWesselMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_EmployeeContributionExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Employee contribution expense.",
                            "label":  "Employee Contribution Expense",
                            "terseLabel":  "Employee contribution expense"
                            }
                        }
                    },
                "localname":  "EmployeeContributionExpense",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/OtherPostretirementBenefitPlanDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_EmployeesAndDirectorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Employees And Directors Member",
                            "terseLabel":  "Employee [Member]",
                            "verboseLabel":  "Employees and Directors [Member]"
                            }
                        }
                    },
                "localname":  "EmployeesAndDirectorsMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_FFEMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "FFEMember",
                            "terseLabel":  "FFE [Member]"
                            }
                        }
                    },
                "localname":  "FFEMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_ForgivenessOfAccountsPayableRelatedToGain":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Forgiveness of accounts payable related to gain.",
                            "label":  "Forgiveness Of Accounts Payable Related To Gain",
                            "terseLabel":  "Forgiveness of accounts payable related to gain"
                            }
                        }
                    },
                "localname":  "ForgivenessOfAccountsPayableRelatedToGain",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_GainOnSettlementsPolicyTectBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A settlement price, in the derivatives markets, is the price used for determining profit or loss for the day, as well as margin requirements.",
                            "label":  "Gain On Settlements Policy Tect Block",
                            "terseLabel":  "Gain on Settlement"
                            }
                        }
                    },
                "localname":  "GainOnSettlementsPolicyTectBlock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "rlmd_GrantedOptions":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Granted options shares.",
                            "label":  "Granted Options",
                            "terseLabel":  "Granted option shares (in Shares)"
                            }
                        }
                    },
                "localname":  "GrantedOptions",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_GrantingToOptionOrStockAwards":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares Granting to option or stock awards.",
                            "label":  "Granting To Option Or Stock Awards",
                            "terseLabel":  "Granting to option or stock awards (in Shares)"
                            }
                        }
                    },
                "localname":  "GrantingToOptionOrStockAwards",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_IncurredExpenseShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "incurred expense shares.",
                            "label":  "Incurred Expense Shares",
                            "terseLabel":  "Incurred expense shares (in Shares)"
                            }
                        }
                    },
                "localname":  "IncurredExpenseShares",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_IncurredNegativeOperatingCashFlows":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incurred negative operating cash flows.",
                            "label":  "Incurred Negative Operating Cash Flows",
                            "terseLabel":  "Incurred negative operating cash flows"
                            }
                        }
                    },
                "localname":  "IncurredNegativeOperatingCashFlows",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_JefferiesLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Jefferies LLCMember",
                            "terseLabel":  "Jefferies LLC [Member]"
                            }
                        }
                    },
                "localname":  "JefferiesLLCMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_LeaseExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lease expense.",
                            "label":  "Lease Expense",
                            "terseLabel":  "Lease expense"
                            }
                        }
                    },
                "localname":  "LeaseExpense",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_LeasePeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Lease period.",
                            "label":  "Lease Period",
                            "terseLabel":  "Lease period"
                            }
                        }
                    },
                "localname":  "LeasePeriod",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_LicenseAgreementDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of license agreement.",
                            "label":  "License Agreement Description",
                            "terseLabel":  "License agreement, description"
                            }
                        }
                    },
                "localname":  "LicenseAgreementDescription",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_LicensesAgreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Licenses agreement.",
                            "label":  "Licenses Agreement",
                            "terseLabel":  "Term of licensing agreement"
                            }
                        }
                    },
                "localname":  "LicensesAgreement",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_LiquidityPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for liquidity activities.",
                            "label":  "Liquidity Policy Text Block",
                            "terseLabel":  "Liquidity"
                            }
                        }
                    },
                "localname":  "LiquidityPolicyTextBlock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "rlmd_MetricsOptions":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Metrics options.",
                            "label":  "Metrics Options",
                            "terseLabel":  "Metrics options (in Shares)"
                            }
                        }
                    },
                "localname":  "MetricsOptions",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_NetIncomeAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income amount.",
                            "label":  "Net Income Amount",
                            "terseLabel":  "Short swing profit, net"
                            }
                        }
                    },
                "localname":  "NetIncomeAmount",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_NetSalesPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of net sales.",
                            "label":  "Net Sales Percentage",
                            "terseLabel":  "Net sales rate"
                            }
                        }
                    },
                "localname":  "NetSalesPercentage",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "rlmd_NonqualifiedStockOptions":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible nonqualified stock options.",
                            "label":  "Nonqualified Stock Options",
                            "terseLabel":  "Nonqualified Stock Options"
                            }
                        }
                    },
                "localname":  "NonqualifiedStockOptions",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_NumberOfSharesWarrantsExercisable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares warrants exercisable.",
                            "label":  "Number Of Shares Warrants Exercisable",
                            "terseLabel":  "Number of Shares, Warrants exercisable"
                            }
                        }
                    },
                "localname":  "NumberOfSharesWarrantsExercisable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_OperatingLossCarryForwardsDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Net operating loss carryforwards, description.",
                            "label":  "Operating Loss Carry Forwards Description",
                            "terseLabel":  "Net operating loss carry forwards description"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryForwardsDescription",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_PatentsPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of patents policy text block.",
                            "label":  "Patents Policy Text Block",
                            "terseLabel":  "Patents"
                            }
                        }
                    },
                "localname":  "PatentsPolicyTextBlock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "rlmd_PaymentForLicense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of payment for license.",
                            "label":  "Payment For License",
                            "terseLabel":  "Pay licensor"
                            }
                        }
                    },
                "localname":  "PaymentForLicense",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_PrepaidExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid Expenses Abstract"
                            }
                        }
                    },
                "localname":  "PrepaidExpensesAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_PrepaidExpensesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid Expenses [Abstract]"
                            }
                        }
                    },
                "localname":  "PrepaidExpensesLineItems",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/PrepaidExpenses"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_PrepaidExpensesTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid Expenses [Table]"
                            }
                        }
                    },
                "localname":  "PrepaidExpensesTable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/PrepaidExpenses"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_PrepaidExpensesTablesLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of prepaid expenses [Abstract]"
                            }
                        }
                    },
                "localname":  "PrepaidExpensesTablesLineItems",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/PrepaidExpensesTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_PrepaidExpensesTablesTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Prepaid Expenses (Tables) [Table]"
                            }
                        }
                    },
                "localname":  "PrepaidExpensesTablesTable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/PrepaidExpensesTables"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_PrepaidExpensesTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure of prepaid expenses.",
                            "label":  "Prepaid Expenses Text Block",
                            "terseLabel":  "PREPAID EXPENSES"
                            }
                        }
                    },
                "localname":  "PrepaidExpensesTextBlock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/PrepaidExpenses"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "rlmd_PrepaidLegal":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Prepaid legal.",
                            "label":  "Prepaid Legal",
                            "terseLabel":  "Legal"
                            }
                        }
                    },
                "localname":  "PrepaidLegal",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofprepaidexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_PrepaidResearchAndDevelopment":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for research and development that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Research And Development",
                            "terseLabel":  "Research and Development"
                            }
                        }
                    },
                "localname":  "PrepaidResearchAndDevelopment",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofprepaidexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_ProceedsFromOptionsExercisedForCommonStock":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Proceeds from options exercised for common stock.",
                            "label":  "Proceeds From Options Exercised For Common Stock",
                            "terseLabel":  "Proceeds from options exercised for common stock"
                            }
                        }
                    },
                "localname":  "ProceedsFromOptionsExercisedForCommonStock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_ProceedsFromShortSwingProfitNet":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of proceeds from short swing profit, net.",
                            "label":  "Proceeds From Short Swing Profit Net",
                            "negatedLabel":  "Proceeds from short swing profit, net"
                            }
                        }
                    },
                "localname":  "ProceedsFromShortSwingProfitNet",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_RelatedPartyTransactionsDetailsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions (Details) [Line Items]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDetailsLineItems",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_RelatedPartyTransactionsDetailsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions (Details) [Table]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDetailsTable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_RentExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of rent expense.",
                            "label":  "Rent Expense",
                            "terseLabel":  "Rent expense"
                            }
                        }
                    },
                "localname":  "RentExpense",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_ScheduleOfAccruedExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Accrued Expenses [Abstract]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccruedExpensesAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfAntiDilutiveSecuritiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule Of Anti Dilutive Securities Abstract"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntiDilutiveSecuritiesAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfChangesInOptionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Changes in Options [Abstract]"
                            }
                        }
                    },
                "localname":  "ScheduleOfChangesInOptionsAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfDeferredTaxAssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Deferred Tax Assets [Abstract]"
                            }
                        }
                    },
                "localname":  "ScheduleOfDeferredTaxAssetsAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfPrepaidExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule Of Prepaid Expenses Abstract"
                            }
                        }
                    },
                "localname":  "ScheduleOfPrepaidExpensesAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfReconcilationOfTheStatutoryTaxRateToTheEffectiveTaxRateAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Reconcilation of the Statutory Tax Rate to the Effective Tax Rate [Abstract]"
                            }
                        }
                    },
                "localname":  "ScheduleOfReconcilationOfTheStatutoryTaxRateToTheEffectiveTaxRateAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfShareBasedCompensationWarrantsActivityTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share warrants (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share warrants or share units that were granted, exercised or converted, forfeited, and expired during the year.",
                            "label":  "Schedule Of Share Based Compensation Warrants Activity Table Text Block",
                            "terseLabel":  "Schedule of the changes in outstanding warrants"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationWarrantsActivityTableTextBlock",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "rlmd_ScheduleOfStockBasedCompensationExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule Of Stock Based Compensation Expense Abstract"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockBasedCompensationExpenseAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfTheChangesInOutstandingWarrantsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of the Changes in Outstanding Warrants [Abstract]"
                            }
                        }
                    },
                "localname":  "ScheduleOfTheChangesInOutstandingWarrantsAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ScheduleOfUnrecognizedStockBasedCompensationExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule Of Unrecognized Stock Based Compensation Expense Abstract"
                            }
                        }
                    },
                "localname":  "ScheduleOfUnrecognizedStockBasedCompensationExpenseAbstract",
                "nsuri":  "http://relmada.com/20221231",
                "xbrltype":  "stringItemType"
                },
            "rlmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedInPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share based compensation arrangement by share based payment award non options issued in period.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Non Options Issued In Period",
                            "terseLabel":  "Number of Shares, Issued"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsIssuedInPeriod",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares exercised.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised",
                            "terseLabel":  "Number of Shares, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Average Remaining Contractual Term (Years), Exercised.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term1",
                            "terseLabel":  "Weighted Average Remaining Contractual Term (Years), Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Average Remaining Contractual Term (Years), Forfeited.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term1",
                            "terseLabel":  "Weighted Average Remaining Contractual Term (Years), Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Average Remaining Contractual Term Year Granted.",
                            "label":  "Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term1",
                            "terseLabel":  "Weighted Average Remaining Contractual Term (Years), Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average exercise price per share.",
                            "label":  "Share Based Compensation Arrangements By Share Based Payment Award Options Exercised In Period Weighted Average Exercise Price",
                            "terseLabel":  "Weighted Average Exercise Price Per Share, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "rlmd_ShortTermOfLeasePaymentsReceivable":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of short term lease payments receivable.",
                            "label":  "Short Term Of Lease Payments Receivable",
                            "terseLabel":  "Lease payments receivable \u2013 short term"
                            }
                        }
                    },
                "localname":  "ShortTermOfLeasePaymentsReceivable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_StockIssuedDuringPeriodSharesWarrantsExercised":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares warrants exercised.",
                            "label":  "Stock Issued During Period Shares Warrants Exercised",
                            "terseLabel":  "Warrants exercised (in Shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesWarrantsExercised",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_StockOptionsExercisablePeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock options exercisable Period.",
                            "label":  "Stock Options Exercisable Period",
                            "terseLabel":  "Stock options exercisable period"
                            }
                        }
                    },
                "localname":  "StockOptionsExercisablePeriod",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_StockOptionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock Options Member",
                            "terseLabel":  "Stock Options [Member]"
                            }
                        }
                    },
                "localname":  "StockOptionsMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_StockholdersEquityDetailsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity (Details) [Line Items]"
                            }
                        }
                    },
                "localname":  "StockholdersEquityDetailsLineItems",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationexpenseLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense [Line Items]"
                            }
                        }
                    },
                "localname":  "StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationexpenseLineItems",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationexpenseTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity (Details) - Schedule of unrecognized stock-based compensation expense [Table]"
                            }
                        }
                    },
                "localname":  "StockholdersEquityDetailsScheduleofunrecognizedstockbasedcompensationexpenseTable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_StockholdersEquityDetailsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity (Details) [Table]"
                            }
                        }
                    },
                "localname":  "StockholdersEquityDetailsTable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_SubsequentEventsDetailsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events (Details) [Line Items]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsDetailsLineItems",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_SubsequentEventsDetailsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events (Details) [Table]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsDetailsTable",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_TermYear":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Vesting period.",
                            "label":  "Term Year",
                            "terseLabel":  "Term year"
                            }
                        }
                    },
                "localname":  "TermYear",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_TotalWarrantsShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares warrants.",
                            "label":  "Total Warrants Shares",
                            "terseLabel":  "Total warrants shares (in Shares)"
                            }
                        }
                    },
                "localname":  "TotalWarrantsShares",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "rlmd_UnderwritersMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Underwriters Member",
                            "terseLabel":  "Underwriters [Member]"
                            }
                        }
                    },
                "localname":  "UnderwritersMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "rlmd_UnrealizedsLossgainOnShorttermInvestments":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrealized gain (loss) on investment.",
                            "label":  "Unrealizeds Lossgain On Shortterm Investments",
                            "negatedLabel":  "Unrealized loss on short-term investments"
                            }
                        }
                    },
                "localname":  "UnrealizedsLossgainOnShorttermInvestments",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "rlmd_VastingPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Vasting period.",
                            "label":  "Vasting Period",
                            "terseLabel":  "Vesting period"
                            }
                        }
                    },
                "localname":  "VastingPeriod",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_VestingPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Vesting percentage.",
                            "label":  "Vesting Percentage",
                            "terseLabel":  "Vesting percentage"
                            }
                        }
                    },
                "localname":  "VestingPercentage",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "rlmd_VestingPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Vesting period.",
                            "label":  "Vesting Period",
                            "terseLabel":  "Vesting period"
                            }
                        }
                    },
                "localname":  "VestingPeriod",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_VolatilityPercentage":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Volatility percentage.",
                            "label":  "Volatility Percentage",
                            "terseLabel":  "Volatility percentage"
                            }
                        }
                    },
                "localname":  "VolatilityPercentage",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "rlmd_WarrantsToConsultantDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrants to consultant description.",
                            "label":  "Warrants To Consultant Description",
                            "terseLabel":  "Warrants to consultant description"
                            }
                        }
                    },
                "localname":  "WarrantsToConsultantDescription",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_WarrantsToConsultantsExercisePriceDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Warrants to consultants exercise price description.",
                            "label":  "Warrants To Consultants Exercise Price Description",
                            "terseLabel":  "Warrants to consultants exercise price description"
                            }
                        }
                    },
                "localname":  "WarrantsToConsultantsExercisePriceDescription",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "rlmd_WeightedAverageExercisePricePerShareExercisedinDollarsPerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Average Exercise Price Per Share, Exercised.",
                            "label":  "Weighted Average Exercise Price Per Share Exercisedin Dollars Per Share",
                            "terseLabel":  "Weighted Average Exercise Price Per Share, Exercised"
                            }
                        }
                    },
                "localname":  "WeightedAverageExercisePricePerShareExercisedinDollarsPerShare",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "rlmd_WeightedAverageExercisePricePerShareIssuedinDollarsPerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Average Exercise Price Per Share, Issued.",
                            "label":  "Weighted Average Exercise Price Per Share Issuedin Dollars Per Share",
                            "terseLabel":  "Weighted Average Exercise Price Per Share, Issued"
                            }
                        }
                    },
                "localname":  "WeightedAverageExercisePricePerShareIssuedinDollarsPerShare",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "rlmd_WeightedAverageExercisePricePerShareOutstandingBeginningBalance1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Average Exercise Price Per Share, Outstanding, Beginning balance",
                            "label":  "Weighted Average Exercise Price Per Share Outstanding Beginning Balance1",
                            "periodEndLabel":  "Weighted Average Exercise Price Per Share, Outstanding, Ending balance",
                            "periodStartLabel":  "Weighted Average Exercise Price Per Share, Outstanding, Beginning balance"
                            }
                        }
                    },
                "localname":  "WeightedAverageExercisePricePerShareOutstandingBeginningBalance1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "rlmd_WeightedAverageExercisePricePerShareWarrantsExercisableinDollarsPerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted Average Exercise Price Per Share, Warrants exercisable",
                            "label":  "Weighted Average Exercise Price Per Share Warrants Exercisablein Dollars Per Share",
                            "terseLabel":  "Weighted Average Exercise Price Per Share, Warrants exercisable"
                            }
                        }
                    },
                "localname":  "WeightedAverageExercisePricePerShareWarrantsExercisableinDollarsPerShare",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "rlmd_WeightedAverageRemainingContractualTermYearsEndingBalance1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contractual term.",
                            "label":  "Weighted Average Remaining Contractual Term Years Ending Balance1",
                            "terseLabel":  "Weighted Average Remaining Contractual Term (Years), Ending balance"
                            }
                        }
                    },
                "localname":  "WeightedAverageRemainingContractualTermYearsEndingBalance1",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "durationItemType"
                },
            "rlmd_WonpungMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Wonpung Member",
                            "terseLabel":  "Wonpung [Member]"
                            }
                        }
                    },
                "localname":  "WonpungMember",
                "nsuri":  "http://relmada.com/20221231",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r201",
                    "r202",
                    "r203",
                    "r204",
                    "r243",
                    "r329",
                    "r348",
                    "r355",
                    "r356",
                    "r366",
                    "r370",
                    "r375",
                    "r407",
                    "r421",
                    "r422",
                    "r423",
                    "r424",
                    "r425",
                    "r426"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]",
                            "terseLabel":  "Maximum [Member]"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails",
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable",
                    "http://relmada.com/role/StockholdersEquityDetails",
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r201",
                    "r202",
                    "r203",
                    "r204",
                    "r243",
                    "r329",
                    "r348",
                    "r355",
                    "r356",
                    "r366",
                    "r370",
                    "r375",
                    "r407",
                    "r421",
                    "r422",
                    "r423",
                    "r424",
                    "r425",
                    "r426"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]",
                            "terseLabel":  "Minimum [Member]"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails",
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable",
                    "http://relmada.com/role/StockholdersEquityDetails",
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r201",
                    "r202",
                    "r203",
                    "r204",
                    "r230",
                    "r243",
                    "r270",
                    "r271",
                    "r272",
                    "r328",
                    "r329",
                    "r348",
                    "r355",
                    "r356",
                    "r366",
                    "r370",
                    "r375",
                    "r402",
                    "r407",
                    "r422",
                    "r423",
                    "r424",
                    "r425",
                    "r426"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails",
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable",
                    "http://relmada.com/role/StockholdersEquityDetails",
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r201",
                    "r202",
                    "r203",
                    "r204",
                    "r230",
                    "r243",
                    "r270",
                    "r271",
                    "r272",
                    "r328",
                    "r329",
                    "r348",
                    "r355",
                    "r356",
                    "r366",
                    "r370",
                    "r375",
                    "r402",
                    "r407",
                    "r422",
                    "r423",
                    "r424",
                    "r425",
                    "r426"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Domain]"
                            }
                        }
                    },
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails",
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable",
                    "http://relmada.com/role/StockholdersEquityDetails",
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_TitleOfIndividualAxis":  {
                "auth_ref":  [
                    "r398",
                    "r417"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Axis]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Domain]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r10"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
                            "label":  "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
                            "terseLabel":  "ACCRUED EXPENSES"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccruedExpenses"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_AccountsPayableCurrent":  {
                "auth_ref":  [
                    "r9",
                    "r374"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accounts Payable, Current",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "AccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedBonusesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r101",
                    "r115"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.",
                            "label":  "Accrued Bonuses",
                            "terseLabel":  "Accrued bonus"
                            }
                        }
                    },
                "localname":  "AccruedBonusesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesAndOtherLiabilities":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
                            "label":  "Accrued Liabilities and Other Liabilities",
                            "totalLabel":  "Total"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesAndOtherLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r12"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Liabilities, Current",
                            "terseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedProfessionalFeesCurrent":  {
                "auth_ref":  [
                    "r12"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Professional Fees, Current",
                            "terseLabel":  "Professional fees"
                            }
                        }
                    },
                "localname":  "AccruedProfessionalFeesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedVacationCurrent":  {
                "auth_ref":  [
                    "r12",
                    "r64"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued Vacation, Current",
                            "terseLabel":  "Accrued vacation"
                            }
                        }
                    },
                "localname":  "AccruedVacationCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedVacationCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r64",
                    "r101",
                    "r115"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees.",
                            "label":  "Accrued Vacation",
                            "terseLabel":  "Accrued vacation"
                            }
                        }
                    },
                "localname":  "AccruedVacationCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r4",
                    "r374"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder.  Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
                            "label":  "Additional Paid in Capital",
                            "terseLabel":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r275",
                    "r276",
                    "r277",
                    "r394",
                    "r395",
                    "r396",
                    "r415"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]",
                            "terseLabel":  "Additional Paid-in Capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.",
                            "label":  "APIC, Share-Based Payment Arrangement, Recognition and Exercise",
                            "terseLabel":  "Additional compensation expense (in Dollars)"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued":  {
                "auth_ref":  [
                    "r52",
                    "r57",
                    "r59"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants.  Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
                            "label":  "Adjustments to Additional Paid in Capital, Warrant Issued",
                            "terseLabel":  "Warrants exercised"
                            }
                        }
                    },
                "localname":  "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Adjustments to reconcile net loss to net cash used in operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "auth_ref":  [
                    "r274"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized.",
                            "label":  "Share-Based Payment Arrangement, Expense",
                            "terseLabel":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r170"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
                            "terseLabel":  "Total"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r96",
                    "r109",
                    "r130",
                    "r147",
                    "r180",
                    "r182",
                    "r184",
                    "r187",
                    "r205",
                    "r206",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r213",
                    "r300",
                    "r302",
                    "r308",
                    "r374",
                    "r405",
                    "r406",
                    "r419"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets",
                            "totalLabel":  "Total assets"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets [Abstract]",
                            "terseLabel":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r126",
                    "r135",
                    "r147",
                    "r187",
                    "r205",
                    "r206",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r213",
                    "r300",
                    "r302",
                    "r308",
                    "r374",
                    "r405",
                    "r406",
                    "r419"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total current assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Assets, Current [Abstract]",
                            "terseLabel":  "Current assets:"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AwardTypeAxis":  {
                "auth_ref":  [
                    "r245",
                    "r246",
                    "r247",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r259",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r266",
                    "r269",
                    "r270",
                    "r271",
                    "r272",
                    "r273"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of award under share-based payment arrangement.",
                            "label":  "Award Type [Axis]"
                            }
                        }
                    },
                "localname":  "AwardTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r36"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the basis of presentation and significant accounting policies concepts.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
                            "label":  "Basis of Presentation and Significant Accounting Policies [Text Block]",
                            "terseLabel":  "Basis of Presentation and Principles of Consolidation"
                            }
                        }
                    },
                "localname":  "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_BusinessAcquisitionAcquireeDomain":  {
                "auth_ref":  [
                    "r299",
                    "r368",
                    "r369"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
                            "label":  "Business Acquisition, Acquiree [Domain]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAcquireeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_BusinessAcquisitionAxis":  {
                "auth_ref":  [
                    "r84",
                    "r85",
                    "r299",
                    "r368",
                    "r369"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by business combination or series of individually immaterial business combinations.",
                            "label":  "Business Acquisition [Axis]"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_BusinessAcquisitionDescriptionOfAcquiredEntity":  {
                "auth_ref":  [
                    "r83"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "With respect to a business combination completed during the period, this element provides a description of the business, other than the name, which may include the industry, size, products and other important information.",
                            "label":  "Business Acquisition, Description of Acquired Entity",
                            "terseLabel":  "Business acquisition, description"
                            }
                        }
                    },
                "localname":  "BusinessAcquisitionDescriptionOfAcquiredEntity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CashAndCashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r33",
                    "r128",
                    "r358"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash and Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "auth_ref":  [
                    "r34"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
                            "label":  "Cash and Cash Equivalents, Policy [Policy Text Block]",
                            "terseLabel":  "Cash and Cash Equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":  {
                "auth_ref":  [
                    "r27",
                    "r33",
                    "r35"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
                            "periodEndLabel":  "Cash and cash equivalents at end of the period",
                            "periodStartLabel":  "Cash and cash equivalents at beginning of the period"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r27",
                    "r94"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
                            "totalLabel":  "Net increase (decrease) in cash and cash equivalents"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashEquivalentsAtCarryingValue":  {
                "auth_ref":  [
                    "r386"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash Equivalents, at Carrying Value",
                            "terseLabel":  "Cash"
                            }
                        }
                    },
                "localname":  "CashEquivalentsAtCarryingValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    "r131",
                    "r132",
                    "r133",
                    "r147",
                    "r164",
                    "r165",
                    "r167",
                    "r169",
                    "r173",
                    "r174",
                    "r187",
                    "r205",
                    "r207",
                    "r208",
                    "r209",
                    "r212",
                    "r213",
                    "r214",
                    "r215",
                    "r217",
                    "r221",
                    "r227",
                    "r308",
                    "r357",
                    "r385",
                    "r392",
                    "r397"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
                            "label":  "Class of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1":  {
                "auth_ref":  [
                    "r228"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise price per share or per unit of warrants or rights outstanding.",
                            "label":  "Class of Warrant or Right, Exercise Price of Warrants or Rights",
                            "terseLabel":  "Exercise price (in Dollars per share)"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights":  {
                "auth_ref":  [
                    "r228"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of securities into which the class of warrant or right may be converted.  For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
                            "label":  "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
                            "terseLabel":  "Exercise of warrants for proceeds (in Shares)"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r14",
                    "r102",
                    "r113"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and Contingencies",
                            "terseLabel":  "Commitments and Contingencies (Note 7)"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r51",
                    "r199",
                    "r200",
                    "r354",
                    "r404"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "Commitments and Contingencies Disclosure [Text Block]",
                            "terseLabel":  "COMMITMENTS AND CONTINGENCIES"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r394",
                    "r395",
                    "r415"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]",
                            "terseLabel":  "Common Stock",
                            "verboseLabel":  "Common Stock [Member]"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockOtherSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares.  May be all or portion of the number of common shares authorized.",
                            "label":  "Common Stock, Other Shares, Outstanding",
                            "terseLabel":  "Common stock outstanding shares (in Shares)"
                            }
                        }
                    },
                "localname":  "CommonStockOtherSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r3"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Common stock, par value (in Dollars per share)"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r3"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common Stock, Shares Authorized",
                            "terseLabel":  "Common stock, shares authorized"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r3"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common Stock, Shares, Issued",
                            "terseLabel":  "Common stock, shares issued"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r3",
                    "r57"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common Stock, Shares, Outstanding",
                            "terseLabel":  "Common stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r3",
                    "r374"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common Stock, Value, Issued",
                            "terseLabel":  "Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 and 27,740,147 shares issued and outstanding, respectively"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CompensationAndRetirementDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Retirement Benefits [Abstract]"
                            }
                        }
                    },
                "localname":  "CompensationAndRetirementDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
                            "label":  "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
                            "terseLabel":  "Schedule of prepaid expenses"
                            }
                        }
                    },
                "localname":  "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/PrepaidExpensesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DeferredOfferingCosts":  {
                "auth_ref":  [
                    "r401"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
                            "label":  "Deferred Offering Costs",
                            "terseLabel":  "Sale of common stock"
                            }
                        }
                    },
                "localname":  "DeferredOfferingCosts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards":  {
                "auth_ref":  [
                    "r82",
                    "r413"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.",
                            "label":  "Deferred Tax Assets, Capital Loss Carryforwards",
                            "terseLabel":  "Capitalized R&D"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsCapitalLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsNet":  {
                "auth_ref":  [
                    "r412"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Net of Valuation Allowance",
                            "terseLabel":  "Total"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign":  {
                "auth_ref":  [
                    "r82",
                    "r413"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.",
                            "label":  "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
                            "terseLabel":  "Federal net operating loss"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal":  {
                "auth_ref":  [
                    "r82",
                    "r413"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
                            "label":  "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
                            "terseLabel":  "State net operating loss"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOther":  {
                "auth_ref":  [
                    "r82",
                    "r413"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
                            "label":  "Deferred Tax Assets, Other",
                            "terseLabel":  "Intangibles and Fixed Assets"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch":  {
                "auth_ref":  [
                    "r81",
                    "r82",
                    "r413"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
                            "label":  "Deferred Tax Assets, Tax Credit Carryforwards, Research",
                            "terseLabel":  "Research and development tax credits"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals":  {
                "auth_ref":  [
                    "r82",
                    "r413"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
                            "terseLabel":  "Accruals"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r286"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
                            "label":  "Deferred Tax Assets, Valuation Allowance",
                            "negatedLabel":  "Less: valuation allowance"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxExpenseFromStockOptionsExercised":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise.",
                            "label":  "Deferred Tax Expense from Stock Options Exercised",
                            "terseLabel":  "Exercise of options"
                            }
                        }
                    },
                "localname":  "DeferredTaxExpenseFromStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Depreciation":  {
                "auth_ref":  [
                    "r31",
                    "r48"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation.",
                            "label":  "Depreciation",
                            "terseLabel":  "Depreciation expense"
                            }
                        }
                    },
                "localname":  "Depreciation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativeContractTypeDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
                            "label":  "Derivative Contract [Domain]"
                            }
                        }
                    },
                "localname":  "DerivativeContractTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DerivativeInstrumentRiskAxis":  {
                "auth_ref":  [
                    "r88",
                    "r89",
                    "r90",
                    "r91",
                    "r361"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of derivative contract.",
                            "label":  "Derivative Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DerivativeInstrumentRiskAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of defined contribution pension and other postretirement plans.",
                            "label":  "Defined Contribution Plan, Description",
                            "terseLabel":  "Employee contributions, description"
                            }
                        }
                    },
                "localname":  "DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/OtherPostretirementBenefitPlanDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EarningsPerShareBasic":  {
                "auth_ref":  [
                    "r142",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r162",
                    "r164",
                    "r167",
                    "r168",
                    "r169",
                    "r171",
                    "r306",
                    "r307",
                    "r345",
                    "r347",
                    "r362"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Basic",
                            "terseLabel":  "Net loss per common share \u2013 basic and diluted (in Dollars per share)"
                            }
                        }
                    },
                "localname":  "EarningsPerShareBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerShareDiluted":  {
                "auth_ref":  [
                    "r142",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r158",
                    "r164",
                    "r167",
                    "r168",
                    "r169",
                    "r171",
                    "r306",
                    "r307",
                    "r345",
                    "r347",
                    "r362"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
                            "label":  "Earnings Per Share, Diluted",
                            "terseLabel":  "Net loss per common share \u2013 Diluted"
                            }
                        }
                    },
                "localname":  "EarningsPerShareDiluted",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement_Parentheticals"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "auth_ref":  [
                    "r37",
                    "r38"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
                            "label":  "Earnings Per Share, Policy [Policy Text Block]",
                            "terseLabel":  "Net Loss per Common Share"
                            }
                        }
                    },
                "localname":  "EarningsPerSharePolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateContinuingOperations":  {
                "auth_ref":  [
                    "r282"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Effective Income Tax Rate Reconciliation, Percent",
                            "terseLabel":  "Effective income tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateContinuingOperations",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":  {
                "auth_ref":  [
                    "r148",
                    "r282",
                    "r294"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
                            "label":  "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
                            "terseLabel":  "Statutory federal income tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r409",
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
                            "label":  "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
                            "terseLabel":  "Change in valuation allowance"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense":  {
                "auth_ref":  [
                    "r409",
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
                            "label":  "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
                            "terseLabel":  "Non-deductible expenses"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments":  {
                "auth_ref":  [
                    "r409",
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
                            "label":  "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
                            "terseLabel":  "R&D Credit"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
                            "label":  "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes":  {
                "auth_ref":  [
                    "r409",
                    "r414"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
                            "label":  "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
                            "terseLabel":  "State (net of federal benefit)"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofreconcilationofthestatutorytaxratetotheeffectivetaxrateTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
                            }
                        }
                    },
                "localname":  "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r57",
                    "r124",
                    "r139",
                    "r140",
                    "r141",
                    "r149",
                    "r150",
                    "r151",
                    "r153",
                    "r159",
                    "r161",
                    "r172",
                    "r188",
                    "r229",
                    "r275",
                    "r276",
                    "r277",
                    "r291",
                    "r292",
                    "r305",
                    "r309",
                    "r310",
                    "r311",
                    "r312",
                    "r313",
                    "r314",
                    "r318",
                    "r349",
                    "r350",
                    "r351"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
                            "label":  "Equity Component [Domain]"
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ExcessStockSharesIssued":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of excess stock shares of an entity that have been sold or granted to shareholders.",
                            "label":  "Excess Stock, Shares Issued",
                            "terseLabel":  "Shares of common stock (in Shares)"
                            }
                        }
                    },
                "localname":  "ExcessStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_FairValueMeasurementPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity.  Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
                            "label":  "Fair Value Measurement, Policy [Policy Text Block]",
                            "terseLabel":  "Fair Value on a Recurring Basis"
                            }
                        }
                    },
                "localname":  "FairValueMeasurementPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FairValueOfFinancialInstrumentsPolicy":  {
                "auth_ref":  [
                    "r92",
                    "r93"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for determining the fair value of financial instruments.",
                            "label":  "Fair Value of Financial Instruments, Policy [Policy Text Block]",
                            "terseLabel":  "Fair Value of Financial Instruments"
                            }
                        }
                    },
                "localname":  "FairValueOfFinancialInstrumentsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r191",
                    "r193",
                    "r194",
                    "r196",
                    "r331",
                    "r332"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by major type or class of finite-lived intangible assets.",
                            "label":  "Finite-Lived Intangible Assets by Major Class [Axis]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r44",
                    "r46"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
                            "label":  "Finite-Lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "FiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_GainLossRelatedToLitigationSettlement":  {
                "auth_ref":  [
                    "r403"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of gain (loss) recognized in settlement of litigation and insurance claims.  Excludes claims within an insurance entity's normal claims settlement process.",
                            "label":  "Gain (Loss) Related to Litigation Settlement",
                            "terseLabel":  "Gain on settlement of fees"
                            }
                        }
                    },
                "localname":  "GainLossRelatedToLitigationSettlement",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GainOnSaleOfInvestments":  {
                "auth_ref":  [
                    "r389",
                    "r390",
                    "r391",
                    "r428",
                    "r429"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The difference between the carrying value and the sale price of an investment.  A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment.  This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
                            "label":  "Gain on Sale of Investments",
                            "terseLabel":  "Unrealized gain"
                            }
                        }
                    },
                "localname":  "GainOnSaleOfInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GainsLossesOnExtinguishmentOfDebt":  {
                "auth_ref":  [
                    "r31",
                    "r53",
                    "r54"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
                            "label":  "Gain (Loss) on Extinguishment of Debt",
                            "negatedLabel":  "Gain on settlement"
                            }
                        }
                    },
                "localname":  "GainsLossesOnExtinguishmentOfDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r21"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "General and Administrative Expense",
                            "terseLabel":  "General and administrative"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpenseMember":  {
                "auth_ref":  [
                    "r20"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption encompassing general and administrative expense.",
                            "label":  "General and Administrative Expense [Member]",
                            "terseLabel":  "General and administrative [Member]"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_GeneralPartnersOfferingCosts":  {
                "auth_ref":  [
                    "r60"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of offering costs allocated to the general partner.",
                            "label":  "General Partners' Offering Costs",
                            "terseLabel":  "Net proceeds from offering (in Dollars)"
                            }
                        }
                    },
                "localname":  "GeneralPartnersOfferingCosts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromEquityMethodInvestments":  {
                "auth_ref":  [
                    "r18",
                    "r31",
                    "r43",
                    "r103",
                    "r116",
                    "r179"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
                            "label":  "Income (Loss) from Equity Method Investments",
                            "negatedLabel":  "Realized loss on short-term investments"
                            }
                        }
                    },
                "localname":  "IncomeLossFromEquityMethodInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationAxis":  {
                "auth_ref":  [
                    "r197",
                    "r198"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by location in the income statement.",
                            "label":  "Income Statement Location [Axis]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeStatementLocationDomain":  {
                "auth_ref":  [
                    "r198"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Location in the income statement.",
                            "label":  "Income Statement Location [Domain]"
                            }
                        }
                    },
                "localname":  "IncomeStatementLocationDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r148",
                    "r283",
                    "r284",
                    "r289",
                    "r293",
                    "r295",
                    "r296",
                    "r297",
                    "r298"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "Income Tax Disclosure [Text Block]",
                            "terseLabel":  "INCOME TAXES"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/IncomeTaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r138",
                    "r280",
                    "r281",
                    "r284",
                    "r285",
                    "r288",
                    "r290"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income Tax, Policy [Policy Text Block]",
                            "terseLabel":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayable":  {
                "auth_ref":  [
                    "r30"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
                            "label":  "Increase (Decrease) in Accounts Payable",
                            "terseLabel":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "auth_ref":  [
                    "r30"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedLabel":  "Other receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccruedLiabilities":  {
                "auth_ref":  [
                    "r30"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
                            "label":  "Increase (Decrease) in Accrued Liabilities",
                            "terseLabel":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInLeasingReceivables":  {
                "auth_ref":  [
                    "r30"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amount due from lessees arising from lease agreements.",
                            "label":  "Increase (Decrease) in Leasing Receivables",
                            "negatedLabel":  "Lease payment receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInLeasingReceivables",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increase (Decrease) in Operating Capital [Abstract]",
                            "terseLabel":  "Change in operating assets and liabilities:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidExpense":  {
                "auth_ref":  [
                    "r30"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
                            "label":  "Increase (Decrease) in Prepaid Expense",
                            "negatedLabel":  "Prepaid expenses and other assets"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis":  {
                "auth_ref":  [
                    "r192",
                    "r195"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
                            "label":  "Indefinite-Lived Intangible Assets [Axis]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain":  {
                "auth_ref":  [
                    "r45",
                    "r47"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill.  A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
                            "label":  "Indefinite-Lived Intangible Assets, Major Class Name [Domain]"
                            }
                        }
                    },
                "localname":  "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_InterestAndOtherIncome":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of interest income and other income recognized during the period.  Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
                            "label":  "Interest and Other Income",
                            "terseLabel":  "Other income expense"
                            }
                        }
                    },
                "localname":  "InterestAndOtherIncome",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestIncomeExpenseNet":  {
                "auth_ref":  [
                    "r105"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net amount of operating interest income (expense).",
                            "label":  "Interest Income (Expense), Net",
                            "terseLabel":  "Interest/investment income, net"
                            }
                        }
                    },
                "localname":  "InterestIncomeExpenseNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InvestmentPolicyTextBlock":  {
                "auth_ref":  [
                    "r186",
                    "r430"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for investment in financial asset.",
                            "label":  "Investment, Policy [Policy Text Block]",
                            "terseLabel":  "Short-term Investments"
                            }
                        }
                    },
                "localname":  "InvestmentPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LeaseExpirationDate1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
                            "label":  "Lease Expiration Date",
                            "terseLabel":  "Lease agreement expiry date"
                            }
                        }
                    },
                "localname":  "LeaseExpirationDate1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "dateItemType"
                },
            "us-gaap_LesseeLeasesPolicyTextBlock":  {
                "auth_ref":  [
                    "r316"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
                            "label":  "Lessee, Leases [Policy Text Block]",
                            "terseLabel":  "Leases"
                            }
                        }
                    },
                "localname":  "LesseeLeasesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_LesseeOperatingLeaseDescription":  {
                "auth_ref":  [
                    "r317"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of lessee's operating lease.",
                            "label":  "Lessee, Operating Lease, Description",
                            "terseLabel":  "Description of lease agreement"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseDescription",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_Liabilities":  {
                "auth_ref":  [
                    "r11",
                    "r147",
                    "r187",
                    "r205",
                    "r206",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r213",
                    "r301",
                    "r302",
                    "r303",
                    "r308",
                    "r363",
                    "r405",
                    "r419",
                    "r420"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
                            "label":  "Liabilities",
                            "totalLabel":  "Total liabilities"
                            }
                        }
                    },
                "localname":  "Liabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r8",
                    "r97",
                    "r111",
                    "r374",
                    "r393",
                    "r399",
                    "r416"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "Total liabilities and stockholders\u2019 equity"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r13",
                    "r127",
                    "r147",
                    "r187",
                    "r205",
                    "r206",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r213",
                    "r301",
                    "r302",
                    "r303",
                    "r308",
                    "r374",
                    "r405",
                    "r419",
                    "r420"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total current liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Liabilities, Current [Abstract]",
                            "terseLabel":  "Current liabilities:"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LicensingAgreementsMember":  {
                "auth_ref":  [
                    "r86"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
                            "label":  "Licensing Agreements [Member]",
                            "terseLabel":  "Licensing Agreements [Member]"
                            }
                        }
                    },
                "localname":  "LicensingAgreementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LossOnSaleOfInvestments":  {
                "auth_ref":  [
                    "r389",
                    "r390",
                    "r391",
                    "r428",
                    "r429"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The difference between the carrying value and the sale price of an investment.  A loss would be recognized when the sale price of the investment is less than the carrying value of the investment.  This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
                            "label":  "Loss on Sale of Investments",
                            "terseLabel":  "Unrealized loss"
                            }
                        }
                    },
                "localname":  "LossOnSaleOfInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r144"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Financing Activities [Abstract]",
                            "terseLabel":  "Cash flows from financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r144"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash provided by (used in) investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Investing Activities [Abstract]",
                            "terseLabel":  "Cash flows from investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r27",
                    "r29",
                    "r32"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "terseLabel":  "Operating cash flows",
                            "totalLabel":  "Net cash used in operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow",
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net Cash Provided by (Used in) Operating Activities [Abstract]",
                            "terseLabel":  "Cash flows from operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r19",
                    "r32",
                    "r104",
                    "r117",
                    "r125",
                    "r136",
                    "r137",
                    "r141",
                    "r147",
                    "r152",
                    "r154",
                    "r155",
                    "r156",
                    "r157",
                    "r160",
                    "r161",
                    "r166",
                    "r180",
                    "r181",
                    "r183",
                    "r185",
                    "r187",
                    "r205",
                    "r206",
                    "r207",
                    "r208",
                    "r209",
                    "r210",
                    "r211",
                    "r212",
                    "r213",
                    "r307",
                    "r308",
                    "r364",
                    "r405"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net Income (Loss) Attributable to Parent",
                            "terseLabel":  "Net loss",
                            "totalLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow",
                    "http://relmada.com/role/ConsolidatedIncomeStatement",
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting.  Includes, but is not limited to, quantification of the expected or actual impact.",
                            "label":  "New Accounting Pronouncements, Policy [Policy Text Block]",
                            "terseLabel":  "Recent Accounting Pronouncements"
                            }
                        }
                    },
                "localname":  "NewAccountingPronouncementsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NoncashInvestingAndFinancingItemsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Noncash Investing and Financing Items [Abstract]",
                            "terseLabel":  "Non-cash investing and financing transactions:"
                            }
                        }
                    },
                "localname":  "NoncashInvestingAndFinancingItemsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r22"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
                            "label":  "Nonoperating Income (Expense)",
                            "totalLabel":  "Total other income (expenses), net"
                            }
                        }
                    },
                "localname":  "NonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingExpenses":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services.  Includes selling, general and administrative expense.",
                            "label":  "Operating Expenses",
                            "totalLabel":  "Total operating expenses"
                            }
                        }
                    },
                "localname":  "OperatingExpenses",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Expenses [Abstract]",
                            "terseLabel":  "Operating expenses:"
                            }
                        }
                    },
                "localname":  "OperatingExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r180",
                    "r181",
                    "r183",
                    "r185",
                    "r364"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "terseLabel":  "Loss from operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r0",
                    "r87"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
                            "label":  "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
                            "terseLabel":  "BUSINESS"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/Business"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r101",
                    "r115"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses incurred but not yet paid classified as other.",
                            "label":  "Other Accrued Liabilities",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherAccruedLiabilitiesCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofaccruedexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssets":  {
                "auth_ref":  [
                    "r95",
                    "r108",
                    "r129"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of assets classified as other.",
                            "label":  "Other Assets",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofdeferredtaxassetsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherAssetsNoncurrent":  {
                "auth_ref":  [
                    "r129"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncurrent assets classified as other.",
                            "label":  "Other Assets, Noncurrent",
                            "terseLabel":  "Other assets"
                            }
                        }
                    },
                "localname":  "OtherAssetsNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpenseAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other Nonoperating Income (Expense) [Abstract]",
                            "terseLabel":  "Other income (expenses):"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpenseAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherPartnersCapital":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of other partners' capital.",
                            "label":  "Other Partners' Capital",
                            "terseLabel":  "Aggregate offering price (in Dollars)"
                            }
                        }
                    },
                "localname":  "OtherPartnersCapital",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherPrepaidExpenseCurrent":  {
                "auth_ref":  [
                    "r387",
                    "r400"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Other Prepaid Expense, Current",
                            "terseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "OtherPrepaidExpenseCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofprepaidexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PayablesAndAccrualsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payables and Accruals [Abstract]"
                            }
                        }
                    },
                "localname":  "PayablesAndAccrualsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PaymentsForRent":  {
                "auth_ref":  [
                    "r28"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash payments to lessor's for use of assets under operating leases.",
                            "label":  "Payments for Rent",
                            "terseLabel":  "Rent amount"
                            }
                        }
                    },
                "localname":  "PaymentsForRent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireInvestments":  {
                "auth_ref":  [
                    "r24"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
                            "label":  "Payments to Acquire Investments",
                            "negatedLabel":  "Purchase of short-term investments"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r230",
                    "r231",
                    "r232",
                    "r233",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r239",
                    "r240",
                    "r241",
                    "r242",
                    "r244",
                    "r367"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for retirement benefits.",
                            "label":  "Retirement Benefits [Text Block]",
                            "terseLabel":  "OTHER POSTRETIREMENT BENEFIT PLAN"
                            }
                        }
                    },
                "localname":  "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/OtherPostretirementBenefitPlan"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PreferredClassAMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock.  Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer.  Classified within temporary equity if redemption is outside the control of the issuer.",
                            "label":  "Preferred Class A [Member]",
                            "terseLabel":  "Class A convertible preferred stock"
                            }
                        }
                    },
                "localname":  "PreferredClassAMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r2",
                    "r214"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred Stock, Par or Stated Value Per Share",
                            "terseLabel":  "Preferred stock par value (in Dollars per share)"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r2"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred Stock, Shares Authorized",
                            "terseLabel":  "Preferred stock, shares authorized"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesIssued":  {
                "auth_ref":  [
                    "r2",
                    "r214"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury).  May be all or portion of the number of preferred shares authorized.  Excludes preferred shares that are classified as debt.",
                            "label":  "Preferred Stock, Shares Issued",
                            "terseLabel":  "Preferred stock, shares issued"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockValue":  {
                "auth_ref":  [
                    "r2",
                    "r374"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Preferred Stock, Value, Issued",
                            "terseLabel":  "Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding",
                            "verboseLabel":  "Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding"
                            }
                        }
                    },
                "localname":  "PreferredStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseCurrent":  {
                "auth_ref":  [
                    "r134",
                    "r189",
                    "r190",
                    "r359"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Expense, Current",
                            "terseLabel":  "Prepaid expenses"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidExpenseCurrentAndNoncurrent":  {
                "auth_ref":  [
                    "r100",
                    "r114",
                    "r134"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.",
                            "label":  "Prepaid Expense",
                            "terseLabel":  "Total"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseCurrentAndNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofprepaidexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PrepaidInsurance":  {
                "auth_ref":  [
                    "r360",
                    "r365",
                    "r400"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid Insurance",
                            "terseLabel":  "Insurance"
                            }
                        }
                    },
                "localname":  "PrepaidInsurance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofprepaidexpensesTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromDebtNetOfIssuanceCosts":  {
                "auth_ref":  [
                    "r143"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
                            "label":  "Proceeds from Debt, Net of Issuance Costs",
                            "terseLabel":  "Net cash proceeds (in Dollars)"
                            }
                        }
                    },
                "localname":  "ProceedsFromDebtNetOfIssuanceCosts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceInitialPublicOffering":  {
                "auth_ref":  [
                    "r25"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
                            "label":  "Proceeds from Issuance Initial Public Offering",
                            "terseLabel":  "ATM offering, net"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceInitialPublicOffering",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r25"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds from Issuance of Common Stock",
                            "terseLabel":  "Proceeds from issuance of common stock"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfWarrants":  {
                "auth_ref":  [
                    "r25"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
                            "label":  "Proceeds from Issuance of Warrants",
                            "terseLabel":  "Exercise of warrants"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfWarrants",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromSaleOfShortTermInvestments":  {
                "auth_ref":  [
                    "r23"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle.  Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
                            "label":  "Proceeds from Sale of Short-Term Investments",
                            "terseLabel":  "Sale of short-term investments"
                            }
                        }
                    },
                "localname":  "ProceedsFromSaleOfShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProfessionalFees":  {
                "auth_ref":  [
                    "r120",
                    "r121"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A fee charged for services from professionals such as doctors, lawyers and accountants.  The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
                            "label":  "Professional Fees",
                            "terseLabel":  "License agreement"
                            }
                        }
                    },
                "localname":  "ProfessionalFees",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r50"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Long-Lived Tangible Asset [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r49"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
                            "label":  "Long-Lived Tangible Asset [Domain]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RealizedInvestmentGainsLosses":  {
                "auth_ref":  [
                    "r118"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of realized gain (loss) on investment.",
                            "label":  "Realized Investment Gains (Losses)",
                            "terseLabel":  "Realized loss on short-term investments"
                            }
                        }
                    },
                "localname":  "RealizedInvestmentGainsLosses",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ReceivablesNetCurrent":  {
                "auth_ref":  [
                    "r112",
                    "r119",
                    "r374"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
                            "label":  "Receivables, Net, Current",
                            "terseLabel":  "Other Receivables"
                            }
                        }
                    },
                "localname":  "ReceivablesNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RelatedPartyDomain":  {
                "auth_ref":  [
                    "r234",
                    "r321",
                    "r322"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Domain]"
                            }
                        }
                    },
                "localname":  "RelatedPartyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionAxis":  {
                "auth_ref":  [
                    "r123",
                    "r321",
                    "r322",
                    "r418"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party transaction.",
                            "label":  "Related Party Transaction [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionDomain":  {
                "auth_ref":  [
                    "r123"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Transaction between related party.",
                            "label":  "Related Party Transaction [Domain]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "auth_ref":  [
                    "r234",
                    "r321",
                    "r333",
                    "r334",
                    "r335",
                    "r336",
                    "r337",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344",
                    "r418"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails",
                    "http://relmada.com/role/RelatedPartyTransactionsDetails",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r319",
                    "r320",
                    "r322",
                    "r323",
                    "r324"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Related Party Transactions Disclosure [Text Block]",
                            "terseLabel":  "RELATED PARTY TRANSACTIONS"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentsOfNotesPayable":  {
                "auth_ref":  [
                    "r26"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
                            "label":  "Repayments of Notes Payable",
                            "negatedLabel":  "Payment of fees for warrants issued for common stock"
                            }
                        }
                    },
                "localname":  "RepaymentsOfNotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "auth_ref":  [
                    "r78",
                    "r122",
                    "r427"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingExpenses",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
                            "label":  "Research and Development Expense",
                            "terseLabel":  "Research and development"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpenseMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary financial statement caption in which the reported facts about research and development expense have been included.",
                            "label":  "Research and Development Expense [Member]",
                            "terseLabel":  "Research and development [Member]"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpenseMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpensePolicy":  {
                "auth_ref":  [
                    "r78"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
                            "label":  "Research and Development Expense, Policy [Policy Text Block]",
                            "terseLabel":  "Research and Development"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpensePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued.  Excludes cash used to satisfy grantee's tax withholding obligation.",
                            "label":  "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
                            "terseLabel":  "Options for shares (in Shares)"
                            }
                        }
                    },
                "localname":  "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r5",
                    "r59",
                    "r110",
                    "r352",
                    "r353",
                    "r374"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings (Accumulated Deficit)",
                            "terseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsAppropriated":  {
                "auth_ref":  [
                    "r17",
                    "r55",
                    "r56",
                    "r106",
                    "r146"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A segregation of retained earnings which is unavailable for dividend distribution.  Includes also retained earnings appropriated for loss contingencies.",
                            "label":  "Retained Earnings, Appropriated",
                            "terseLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAppropriated",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r124",
                    "r149",
                    "r150",
                    "r151",
                    "r153",
                    "r159",
                    "r161",
                    "r188",
                    "r275",
                    "r276",
                    "r277",
                    "r291",
                    "r292",
                    "r305",
                    "r349",
                    "r351"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]",
                            "terseLabel":  "Accumulated Deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockNameOfTransactionDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
                            "label":  "Sale of Stock [Domain]"
                            }
                        }
                    },
                "localname":  "SaleOfStockNameOfTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SaleOfStockPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
                            "label":  "Sale of Stock, Price Per Share",
                            "terseLabel":  "Price per share (in Dollars per share)"
                            }
                        }
                    },
                "localname":  "SaleOfStockPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of accrued liabilities.",
                            "label":  "Schedule of Accrued Liabilities [Table Text Block]",
                            "terseLabel":  "Schedule of accrued expenses"
                            }
                        }
                    },
                "localname":  "ScheduleOfAccruedLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccruedExpensesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable":  {
                "auth_ref":  [
                    "r37"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock":  {
                "auth_ref":  [
                    "r37"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
                            "label":  "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
                            "terseLabel":  "Schedule of anti-dilutive securities"
                            }
                        }
                    },
                "localname":  "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    "r80"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
                            "label":  "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
                            "terseLabel":  "Schedule of deferred tax assets"
                            }
                        }
                    },
                "localname":  "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock":  {
                "auth_ref":  [
                    "r79"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
                            "label":  "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
                            "terseLabel":  "Schedule of reconcilation of the statutory tax rate to the effective tax rate"
                            }
                        }
                    },
                "localname":  "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable":  {
                "auth_ref":  [
                    "r75",
                    "r77"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about amount recognized for award under share-based payment arrangement.  Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
                            "label":  "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock":  {
                "auth_ref":  [
                    "r75"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position.  Includes, but is not limited to, corresponding line item in financial statement.",
                            "label":  "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
                            "terseLabel":  "Schedule of stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock":  {
                "auth_ref":  [
                    "r65",
                    "r69",
                    "r71"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure for stock option plans.  Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
                            "label":  "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
                            "terseLabel":  "Schedule of the changes in outstanding warrants"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock":  {
                "auth_ref":  [
                    "r373",
                    "r411"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the change in unrecognized tax benefits.",
                            "label":  "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
                            "terseLabel":  "Schedule of unrecognized stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SeveranceCosts1":  {
                "auth_ref":  [
                    "r31"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan.  Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
                            "label":  "Severance Costs",
                            "terseLabel":  "Severance fees"
                            }
                        }
                    },
                "localname":  "SeveranceCosts1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r30"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedCashFlow":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Share-Based Payment Arrangement, Noncash Expense",
                            "terseLabel":  "Stock-based compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedCashFlow"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1":  {
                "auth_ref":  [
                    "r371"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.  Includes, but is not limited to, combination of market, performance or service condition.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
                            "terseLabel":  "Vesting period"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails",
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r260"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
                            "terseLabel":  "Number of Shares, Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":  {
                "auth_ref":  [
                    "r271"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
                            "terseLabel":  "Expected dividends rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":  {
                "auth_ref":  [
                    "r270"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
                            "terseLabel":  "Expected volatility rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
                            "terseLabel":  "Volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":  {
                "auth_ref":  [
                    "r272"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
                            "terseLabel":  "Risk free interest rate",
                            "verboseLabel":  "Discount rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised":  {
                "auth_ref":  [
                    "r68"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of non-option equity instruments exercised by participants.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
                            "negatedLabel":  "Number of Shares, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOtherDescription":  {
                "auth_ref":  [
                    "r65"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of reason for increase (decrease), classified as other, in number of awards under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Other, Description",
                            "terseLabel":  "Stock based compensation, description"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOtherDescription",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber":  {
                "auth_ref":  [
                    "r66",
                    "r67"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
                            "periodEndLabel":  "Number of Shares, Outstanding, Ending balance",
                            "periodStartLabel":  "Number of Shares, Outstanding, Beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofthechangesinoutstandingwarrantsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":  {
                "auth_ref":  [
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
                            "terseLabel":  "Number of Shares, Options exercisable"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r251"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
                            "terseLabel":  "Weighted Average Exercise Price Per Share, Options exercisable"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod":  {
                "auth_ref":  [
                    "r255"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
                            "negatedLabel":  "Number of Shares, Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    "r253"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
                            "terseLabel":  "Number of granted option (in Shares)"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease":  {
                "auth_ref":  [
                    "r408"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease)",
                            "terseLabel":  "Stock options awarded"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue":  {
                "auth_ref":  [
                    "r265"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding.  Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
                            "periodEndLabel":  "Aggregate Intrinsic Value, Outstanding and expected to vest, Ending balance",
                            "periodStartLabel":  "Aggregate Intrinsic Value, Outstanding and expected to vest, Beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber":  {
                "auth_ref":  [
                    "r265"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan.  Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
                            "periodEndLabel":  "Number of Shares, Outstanding and expected to vest, Ending balance",
                            "periodStartLabel":  "Number of Shares, Outstanding and expected to vest, Beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r265"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding.  Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
                            "periodEndLabel":  "Weighted Average Exercise Price Per Share, Outstanding and expected to vest, Ending balance",
                            "periodStartLabel":  "Weighted Average Exercise Price Per Share, Outstanding and expected to vest, Beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain":  {
                "auth_ref":  [
                    "r245",
                    "r246",
                    "r247",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r259",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r266",
                    "r269",
                    "r270",
                    "r271",
                    "r272",
                    "r273"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Award under share-based payment arrangement.",
                            "label":  "Award Type [Domain]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r255"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Weighted Average Exercise Price Per Share, Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r253"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
                            "label":  "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
                            "terseLabel":  "Weighted Average Exercise Price Per Share, Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "auth_ref":  [
                    "r248",
                    "r267",
                    "r268",
                    "r269",
                    "r270",
                    "r273",
                    "r278",
                    "r279"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost.",
                            "label":  "Share-Based Payment Arrangement [Policy Text Block]",
                            "terseLabel":  "Stock-Based Compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit":  {
                "auth_ref":  [
                    "r74"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
                            "label":  "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
                            "terseLabel":  "Exercise price ranging"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod":  {
                "auth_ref":  [
                    "r372"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
                            "terseLabel":  "Underwriters granted period"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1":  {
                "auth_ref":  [
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
                            "terseLabel":  "Expected term (in years)",
                            "verboseLabel":  "Expected life term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofunrecognizedstockbasedcompensationexpenseTable",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1":  {
                "auth_ref":  [
                    "r76"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
                            "terseLabel":  "Aggregate Intrinsic Value, Options exercisable"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    "r76"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Weighted Average Remaining Contractual Term (Years), Options exercisable"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    "r265"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.  Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Weighted Average Remaining Contractual Term (Years), Beginning balance"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofchangesinoptionsTable"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1":  {
                "auth_ref":  [
                    "r264"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value of options vested.  Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
                            "terseLabel":  "Aggregate fair value of options (in Dollars)"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r73"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Exercise term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r72"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
                            "terseLabel":  "Term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharesIssued":  {
                "auth_ref":  [
                    "r57"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
                            "label":  "Shares, Issued",
                            "terseLabel":  "Available shares to be issued (in Shares)"
                            }
                        }
                    },
                "localname":  "SharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Balance (in Shares)",
                            "periodStartLabel":  "Balance (in Shares)"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShortTermInvestments":  {
                "auth_ref":  [
                    "r98",
                    "r99",
                    "r107",
                    "r388"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
                            "label":  "Short-Term Investments",
                            "terseLabel":  "Short-term investments",
                            "verboseLabel":  "Short-term investment instruments"
                            }
                        }
                    },
                "localname":  "ShortTermInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet",
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShorttermDebtFairValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure.  Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.  The element may be used in both the balance sheet and disclosure in the same submission.  This item represents the amount of short-term debt existing as of the balance sheet date.",
                            "label":  "Short-Term Debt, Fair Value",
                            "terseLabel":  "Short-term investments fair value"
                            }
                        }
                    },
                "localname":  "ShorttermDebtFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPoliciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r36",
                    "r145"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "Significant Accounting Policies [Text Block]",
                            "terseLabel":  "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SummaryofSignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r131",
                    "r132",
                    "r133",
                    "r147",
                    "r164",
                    "r165",
                    "r167",
                    "r169",
                    "r173",
                    "r174",
                    "r187",
                    "r205",
                    "r207",
                    "r208",
                    "r209",
                    "r212",
                    "r213",
                    "r214",
                    "r215",
                    "r217",
                    "r221",
                    "r227",
                    "r308",
                    "r357",
                    "r385",
                    "r392",
                    "r397"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r15",
                    "r57",
                    "r124",
                    "r139",
                    "r140",
                    "r141",
                    "r149",
                    "r150",
                    "r151",
                    "r153",
                    "r159",
                    "r161",
                    "r172",
                    "r188",
                    "r229",
                    "r275",
                    "r276",
                    "r277",
                    "r291",
                    "r292",
                    "r305",
                    "r309",
                    "r310",
                    "r311",
                    "r312",
                    "r313",
                    "r314",
                    "r318",
                    "r349",
                    "r350",
                    "r351"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals",
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Stockholders' Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r149",
                    "r150",
                    "r151",
                    "r172",
                    "r330"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals",
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of preferred stock and warrants for common stock issued.",
                            "label":  "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
                            "terseLabel":  "Net exercise -Prefunded warrants",
                            "verboseLabel":  "Warrants vested and outstanding (in Dollars)"
                            }
                        }
                    },
                "localname":  "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits":  {
                "auth_ref":  [
                    "r2",
                    "r3",
                    "r57",
                    "r58",
                    "r59"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued during the period upon the conversion of units.  An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
                            "label":  "Stock Issued During Period, Shares, Conversion of Units",
                            "terseLabel":  "Net exercise -Prefunded warrants (in Shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesConversionOfUnits",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r2",
                    "r3",
                    "r57",
                    "r59"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Stock Issued During Period, Shares, New Issues",
                            "terseLabel":  "ATM offering, net (in Shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesOther":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued attributable to transactions classified as other.",
                            "label":  "Stock Issued During Period, Shares, Other",
                            "terseLabel":  "Equity offering, net (in Shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesPeriodIncreaseDecrease":  {
                "auth_ref":  [
                    "r57"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the period in the number of shares issued.",
                            "label":  "Stock Issued During Period, Shares, Period Increase (Decrease)",
                            "terseLabel":  "Common stock issued (in Shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesPeriodIncreaseDecrease",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r2",
                    "r3",
                    "r57",
                    "r59",
                    "r254"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
                            "netLabel":  "Srock options issued",
                            "terseLabel":  "Options exercised (in Shares)",
                            "verboseLabel":  "Exercise price (in Shares)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/RelatedPartyTransactionsDetails",
                    "http://relmada.com/role/ShareholdersEquityType2or3",
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueAcquisitions":  {
                "auth_ref":  [
                    "r15",
                    "r57",
                    "r59"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued pursuant to acquisitions during the period.",
                            "label":  "Stock Issued During Period, Value, Acquisitions",
                            "terseLabel":  "Aggregate of offering price (in Dollars)"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueAcquisitions",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r2",
                    "r3",
                    "r57",
                    "r59"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Stock Issued During Period, Value, New Issues",
                            "terseLabel":  "Share exchange -Prefunded warrants, net of fees"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueOther":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of shares of stock issued attributable to transactions classified as other.",
                            "label":  "Stock Issued During Period, Value, Other",
                            "terseLabel":  "Equity offering, net"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation":  {
                "auth_ref":  [
                    "r2",
                    "r3",
                    "r59",
                    "r70"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value, after forfeiture, of shares issued under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
                            "terseLabel":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised":  {
                "auth_ref":  [
                    "r15",
                    "r57",
                    "r59"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued as a result of the exercise of stock options.",
                            "label":  "Stock Issued During Period, Value, Stock Options Exercised",
                            "terseLabel":  "Options exercised"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockOptionExercisePriceIncrease":  {
                "auth_ref":  [
                    "r228"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share increase in exercise price of option.  Excludes change due to standard antidilution provision and option granted under share-based payment arrangement.",
                            "label":  "Stock Option, Exercise Price, Increase",
                            "terseLabel":  "Exercise price (in Dollars per share)"
                            }
                        }
                    },
                "localname":  "StockOptionExercisePriceIncrease",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_StockOptionMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
                            "label":  "Equity Option [Member]",
                            "terseLabel":  "Common stock options [Member]",
                            "verboseLabel":  "Equity Option [Member]"
                            }
                        }
                    },
                "localname":  "StockOptionMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ScheduleofantidilutivesecuritiesTable",
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_StockRepurchasedDuringPeriodShares":  {
                "auth_ref":  [
                    "r2",
                    "r3",
                    "r57",
                    "r59"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury.  Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore.  This element is used when state law does not recognize treasury stock.",
                            "label":  "Stock Repurchased During Period, Shares",
                            "terseLabel":  "Share exchange -Prefunded warrants, net of fees (in Shares)"
                            }
                        }
                    },
                "localname":  "StockRepurchasedDuringPeriodShares",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r3",
                    "r6",
                    "r7",
                    "r42",
                    "r374",
                    "r393",
                    "r399",
                    "r416"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedBalanceSheet":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "periodEndLabel":  "Balance",
                            "periodStartLabel":  "Balance",
                            "totalLabel":  "Total stockholders\u2019 equity"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet",
                    "http://relmada.com/role/ShareholdersEquityType2or3"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity Attributable to Parent [Abstract]",
                            "terseLabel":  "Stockholders\u2019 Equity:"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders' Equity Note [Abstract]"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r63",
                    "r146",
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r219",
                    "r220",
                    "r221",
                    "r222",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r229",
                    "r304"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "Stockholders' Equity Note Disclosure [Text Block]",
                            "terseLabel":  "STOCKHOLDERS' EQUITY"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquity"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsequentEventMember":  {
                "auth_ref":  [
                    "r315",
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event [Member]",
                            "terseLabel":  "Subsequent Event [Member]"
                            }
                        }
                    },
                "localname":  "SubsequentEventMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventTypeAxis":  {
                "auth_ref":  [
                    "r315",
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event Type [Axis]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEventsDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for reporting subsequent events.",
                            "label":  "Subsequent Events, Policy [Policy Text Block]",
                            "terseLabel":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "auth_ref":  [
                    "r325",
                    "r327"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
                            "label":  "Subsequent Events [Text Block]",
                            "terseLabel":  "SUBSEQUENT EVENTS"
                            }
                        }
                    },
                "localname":  "SubsequentEventsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/SubsequentEvents"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsidiarySaleOfStockAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of sale of the entity's stock.",
                            "label":  "Sale of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "SubsidiarySaleOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TaxCreditCarryforwardAmount":  {
                "auth_ref":  [
                    "r81"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
                            "label":  "Tax Credit Carryforward, Amount",
                            "terseLabel":  "Federal tax credit carryforwards"
                            }
                        }
                    },
                "localname":  "TaxCreditCarryforwardAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_TemporaryEquitySharesOutstanding":  {
                "auth_ref":  [
                    "r1"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders.  Securities outstanding equals securities issued minus securities held in treasury.  Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.  Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer.  If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity.  If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases.  Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
                            "label":  "Temporary Equity, Shares Outstanding",
                            "terseLabel":  "Preferred stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "TemporaryEquitySharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedBalanceSheet_Parentheticals"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_TreasuryStockCommonValue":  {
                "auth_ref":  [
                    "r16",
                    "r61",
                    "r62"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
                            "label":  "Treasury Stock, Common, Value",
                            "terseLabel":  "Treasury stock (in Dollars)"
                            }
                        }
                    },
                "localname":  "TreasuryStockCommonValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UnearnedPremiums":  {
                "auth_ref":  [
                    "r346"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount of premiums written on insurance contracts that have not been earned as of the balance sheet date.",
                            "label":  "Unearned Premiums",
                            "terseLabel":  "Unearned interest income"
                            }
                        }
                    },
                "localname":  "UnearnedPremiums",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/CommitmentsandContingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UnrealizedGainLossOnInvestments":  {
                "auth_ref":  [
                    "r31"
                    ],
                "calculation":  {
                    "http://relmada.com/role/ConsolidatedIncomeStatement":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NonoperatingIncomeExpense",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of unrealized gain (loss) on investment.",
                            "label":  "Unrealized Gain (Loss) on Investments",
                            "terseLabel":  "Unrealized loss on short-term investments"
                            }
                        }
                    },
                "localname":  "UnrealizedGainLossOnInvestments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense":  {
                "auth_ref":  [
                    "r410"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest expense for an underpayment of income taxes.",
                            "label":  "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
                            "terseLabel":  "Stock-based compensation expense (in Dollars)"
                            }
                        }
                    },
                "localname":  "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r39",
                    "r40",
                    "r41",
                    "r175",
                    "r176",
                    "r177",
                    "r178"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates, Policy [Policy Text Block]",
                            "terseLabel":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/AccountingPoliciesByPolicy"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount":  {
                "auth_ref":  [
                    "r287"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
                            "label":  "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
                            "terseLabel":  "Valuation allowance increase decrease"
                            }
                        }
                    },
                "localname":  "ValuationAllowanceDeferredTaxAssetChangeInAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_WarrantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
                            "label":  "Warrant [Member]",
                            "terseLabel":  "Warrant [Member]"
                            }
                        }
                    },
                "localname":  "WarrantMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/StockholdersEquityDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding":  {
                "auth_ref":  [
                    "r163",
                    "r169"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Diluted",
                            "terseLabel":  "Weighted average number of common shares outstanding \u2013 Diluted"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfDilutedSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement_Parentheticals"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic":  {
                "auth_ref":  [
                    "r162",
                    "r169"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
                            "label":  "Weighted Average Number of Shares Outstanding, Basic",
                            "terseLabel":  "Weighted average number of common shares outstanding \u2013 basic and diluted (in Shares)"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfSharesOutstandingBasic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://relmada.com/role/ConsolidatedIncomeStatement"
                    ],
                "xbrltype":  "sharesItemType"
                }
            },
        "unitCount":  4
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/topic&trid=2122149",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a),20,24)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.10)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.15(5))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(13)(f))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04.10)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(23)(a)(4)(i))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(1)(g))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(10))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(5))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.10)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.15(a))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(10))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04.3(a))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.6-06(3))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "220",
        "Subparagraph":  "(k)",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.6-07.2(a),(b),(c),(d))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "985",
        "URI":  "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(25))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(2))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.30)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(30)(a)(3)(ii))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(12))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(1)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "420",
        "URI":  "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(4))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q4)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.7)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iii)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(iv)(03)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(l)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(o)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(p)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(q)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(r)(1)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(r)(2)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "60",
        "Subparagraph":  "(c)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "70",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/topic&trid=2235017",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(04)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(v)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.D.2.Q6)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/topic&trid=2228938",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.5.Q1)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.4)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.C)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "270",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/topic&trid=2144680",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(4)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(1)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/topic&trid=2122745",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/topic&trid=2122774",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "926",
        "URI":  "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "340",
        "Topic":  "928",
        "URI":  "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(1)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(2)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(27))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(13)(a)(2))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(23))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "440",
        "Subparagraph":  "(a)",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(c)",
        "Topic":  "976",
        "URI":  "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "978",
        "URI":  "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r357":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(a)",
        "Publisher":  "SEC",
        "Section":  "1402",
        "role":  "http://www.xbrl.org/2003/role/disclosureRef"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/topic&trid=2122369",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)(1)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "52",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(a)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "217",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
        "role":  "http://www.xbrl.org/2003/role/exampleRef"
        },
    "r376":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r377":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r378":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r379":  {
        "Name":  "Form 10-K",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "310",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r380":  {
        "Name":  "Form 20-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "220",
        "Subsection":  "f",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r381":  {
        "Name":  "Form 40-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "240",
        "Subsection":  "f",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r382":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r383":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r384":  {
        "Name":  "Securities Act",
        "Number":  "230",
        "Publisher":  "SEC",
        "Section":  "405",
        "role":  "http://www.xbrl.org/2003/role/presentationRef"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
        "role":  "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(8))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(b)(7)(c))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(b)(9)(a))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "55",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.A)",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "410",
        "URI":  "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/topic&trid=2127136",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.4)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r423":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r424":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r425":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r426":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r427":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "730",
        "Topic":  "912",
        "URI":  "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r428":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(13))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r429":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(3)(a))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r430":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(3)(b))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
        "role":  "http://www.xbrl.org/2009/role/commonPracticeRef"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/topic&trid=2144648",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "40",
        "SubTopic":  "50",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "40",
        "SubTopic":  "50",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21332-112643",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21346-112643",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 4.F)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/topic&trid=2208762",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "710",
        "URI":  "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.F)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "730",
        "URI":  "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "805",
        "URI":  "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/topic&trid=2197479",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "60",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(10))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(4))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(5))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
        "role":  "http://fasb.org/us-gaap/role/ref/legacyRef"
        }
    },
"version":  "2.2"
}


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/21/23  Relmada Therapeutics, Inc.        S-8         6/21/23    4:202K                                   EdgarAgents LLC/FA


29 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/17/23  Relmada Therapeutics, Inc.        8-K:1,5,9   1/12/23   12:289K                                   EdgarAgents LLC/FA
 1/05/23  Relmada Therapeutics, Inc.        8-K:1,8,9   1/01/23   11:248K                                   EdgarAgents LLC/FA
12/28/22  Relmada Therapeutics, Inc.        8-K:1,9    12/27/22   11:209K                                   EdgarAgents LLC/FA
 9/22/22  Relmada Therapeutics, Inc.        8-K:1,3,5,9 9/21/22   13:939K                                   EdgarAgents LLC/FA
 8/10/21  Relmada Therapeutics, Inc.        10-Q        6/30/21   54:3.4M                                   EdgarAgents LLC/FA
 3/24/21  Relmada Therapeutics, Inc.        10-K       12/31/20   65:4.7M                                   EdgarAgents LLC/FA
 8/12/20  Relmada Therapeutics, Inc.        S-3                    3:499K                                   EdgarAgents LLC/FA
 5/15/20  Relmada Therapeutics, Inc.        10-Q        3/31/20   54:2.7M                                   EdgarAgents LLC/FA
 3/09/20  Relmada Therapeutics, Inc.        8-K:1,5,9   3/06/20    2:33K                                    EdgarAgents LLC/FA
 1/10/20  Relmada Therapeutics, Inc.        8-K:1,5,9   1/09/20    4:294K                                   EdgarAgents LLC/FA
12/26/19  Relmada Therapeutics, Inc.        8-K:5,8,9  12/19/19    6:200K                                   EdgarAgents LLC/FA
12/03/19  Relmada Therapeutics, Inc.        8-K:1,8,9  11/27/19    6:7.7M                                   EdgarAgents LLC/FA
11/13/19  Relmada Therapeutics, Inc.        10-Q        9/30/19   56:2.7M                                   EdgarAgents LLC/FA
 9/27/19  Relmada Therapeutics, Inc.        8-K:3,5,9   9/26/19    3:254K                                   EdgarAgents LLC/FA
 5/15/19  Relmada Therapeutics, Inc.        10-Q        3/31/19   66:5M                                     EdgarAgents LLC/FA
11/13/18  Relmada Therapeutics, Inc.        10-Q        9/30/18   61:3.2M                                   EdgarAgents LLC/FA
 5/14/18  Relmada Therapeutics, Inc.        10-Q        3/31/18   62:3M                                     EdgarAgents LLC/FA
 2/12/18  Relmada Therapeutics, Inc.        10-Q       12/31/17   62:2.9M                                   EdgarAgents LLC/FA
 1/19/18  Relmada Therapeutics, Inc.        8-K:1,9     1/16/18    4:247K                                   EdgarAgents LLC/FA
11/25/15  Relmada Therapeutics, Inc.        8-K:5,9    11/20/15    2:151K                                   EdgarAgents LLC/FA
 8/07/15  Relmada Therapeutics, Inc.        8-K:1,5,9   8/03/15    8:532K                                   EdgarAgents LLC/FA
 7/16/15  Relmada Therapeutics, Inc.        8-K:5,8,9   7/14/15    4:147K                                   EdgarAgents LLC/FA
12/09/14  Relmada Therapeutics, Inc.        S-1/A                 65:10M                                    EdgarAgents LLC/FA
 9/09/14  Relmada Therapeutics, Inc.        10-KT       6/30/14   65:8.3M                                   EdgarAgents LLC/FA
 6/16/14  Relmada Therapeutics, Inc.        8-K:1,3,9   6/10/14    7:916K                                   EdgarAgents LLC/FA
 6/02/14  Relmada Therapeutics, Inc.        8-K:5,9     5/30/14    2:574K                                   EdgarAgents LLC/FA
 5/27/14  Relmada Therapeutics, Inc.        8-K:1,2,3,4 5/20/14   93:13M                                    EdgarAgents LLC/FA
 5/19/14  Relmada Therapeutics, Inc.        8-K:3,9     5/14/14    2:46K                                    Clark Corp Law Group LLP
11/13/12  Relmada Therapeutics, Inc.        S-1        11/09/12    5:644K                                   Clark Corp Law Group LLP
Top
Filing Submission 0001213900-23-022463   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 1:23:20.7pm ET